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Chapter I 
Introduction 
Adapted from Kwaadaardige nieuwvormingen. 
D.J.Th. Wagener, J.W.W. Coebergh en A. Sewnaik 
Tabaksgebruik:gevolgen en bestrijding. 2005 
 
Head and neck cancer accounts for about five percent of all human cancers.  
In 1998 twenty-three hundred new patients were diagnosed with head and neck cancer in 
the Netherlands.1 About ninety percent of all head and neck cancers are squamous cell 
carcinoma.2 (Table I)  Of these laryngeal carcinoma is the most frequent involved site in 
males and the third most frequent involved site in females.  
The incidence in the Netherlands in 1998 for males was 7.6 per 100.000 person-years.  
For females the incidence was 1.2 per 100.000 person-years.  
The male-female ratio was 6.3:1. In the period between 1989 and 1998 the incidence 
decreased for males and increased for females. The incidence for hypopharyngeal 
carcinoma in the Netherlands in 1998 was 1.8 per 100.000 person-years for males  
and 0.3 per 100.000 person-years for females. The male-female ratio cancer was 6:1.  
Since 1998 the incidence of hypopharyngeal cancer both for males and females has 
increased.1 Smoking is the most important risk factor for laryngeal cancer both for males 
and females, while especially the combination of  smoking and alcohol abuse is 
considered to be an important combination in the development of hypopharyngeal 
cancers.
Smoking and squamous cell carcinoma 
Tobacco smoke contains a number of substances which cause genetic  
mutations leading to DNA-adducts. DNA adducts originate after exposure 
to polycyclic aromatic hydrocarbon (PAH), nitro hydrocarbon and aromatic amines  
(all of them found in tobacco smoke).3,4 It has been demonstrated that there are 
significant more DNA adducts in malignant tumours than in healthy tissue.  
Also more DNA adducts are found in tissue of recurrent tumours than in primary 
tumors.3 This might be caused by permanent damage to the DNA-repair system.  
The amount of DNA adducts is higher in males than in females at equal  
exposure to tobacco which has so far not been explained.3
Some gene mutations have an effect on the carcinogenesis, such as proto-oncogenes and 
tumour-suppressor genes. In head and neck cancer mutations in P53- and P16-tumor 
suppressor genes appear frequently.3,4
These tumour suppressor genes take care for the negative regulation of cell growth. 
For head and neck cancer the P53 gene is more important than the P16 gene.  
A mutation in the P53 gene causes accumulation of the P53 protein.  
The tumour suppression is lost and  uncontrolled cell growth appears. 
Uncontrolled cell growth also appears because of mutation caused by tobacco smoke in 
proto-oncogenes. The proto-oncogenes are converted into oncogenes (H-ras),  
which cause the cell growth.  
 
Glutathione-S- enzyme system causes detoxification in the cells.  
Tobacco smoke also causes mutations in this system and the carcinogenic substances 
cannot be removed from the cell.  
Substances in tobacco smoke, which cause degeneration of squamous cell epithelium, 
deregulate different enzyme systems and cell regulating systems. 
Alcohol is also an important risk factor, especially for those sites where it has direct 
contact with the mucosa (oral cavity, pharynx and- oesophagus).5
The tumour promoting effect of alcohol is not cleared. 
It seems that the metabolite of alcohol, acetaldehyde, is the toxic factor.6
It is suspected that acetaldehyde influences the tumour suppressor cells.  
This might cause uncontrollable cell growth. 
In the Netherlands, a consensus guideline for treatment of laryngeal cancer has been 
established in 1999.7 The primary treatment goal is tumour control. The choice of 
treatment is however also influenced by other factors, such as the expected quality of life 
outcome. Preservation of a functional larynx, if possible, is important in the treatment of 
laryngeal cancer.  
The choice of organ preservation therapy does not have a negative effect on life 
expectancy in most patients. Therefore, the primary treatment for the majority of 
laryngeal cancers is radiotherapy or minimal invasive surgery. Only in advanced cases 
(see chapter 7) primary laryngectomy in combination with radiotherapy is indicated. 
Tumours, however, do recur after radiotherapy in 10-50% of the cases depending on 
stage of the primary tumour. In case of recurrent laryngeal cancer, the golden standard 
of treatment is a total laryngectomy.  
In chapter 2 it is shown that in selected cases with recurrent laryngeal cancer a 
functional larynx can be preserved. A partial laryngectomy (endoscopic CO2-laser and 
frontolateral partial laryngectomy) can be a good alternative for a total laryngectomy.  
A third partial procedure performed in our hospital is the cricohyoidoepiglottopexy. 
Chapter 3 discusses the cricohyoidoepiglottopexy as organ preservation salvage 
treatment with good functional outcome. The reason to perform salvage partial 
laryngectomies is the expected better of quality of life outcome, compared to total 
laryngectomy. Chapter 4 discusses the QoL after partial laryngectomy versus total 
laryngectomy . 
Squamous cell carcinoma of the hypopharynx is relatively rare and has the worst 
prognoses of all head and neck cancers. In the 1970s most patients were treated with 
surgery, radiotherapy or a combination of these two treatment modalities.8 The 5-year 
survival rate for combined surgery with radiotherapy varies between 25% and 60%.8,9
For the purpose of improving survival rates as well as the preservation of the larynx, a 
third treatment modality, chemotherapy, mostly in combination with radiotherapy, was 
introduced. Unlike laryngeal cancer, there is no consensus guideline in the Netherlands 
for treatment of hypopharyngeal cancer yet. An inventory of treatment approaches for 
hypopharyngeal cancers in eight centres in the Netherlands was initiated by the 
National Head and Neck tumourboard (NWHHT) in 1984.  
 
The results of this study are summarized in chapter 5. Between 1985 and 1994 most 
patients were treated with radiotherapy or a combination of surgery and radiotherapy. 
In the nineties, a new organ preservation approach, radiotherapy combined with 
chemotherapy became increasingly popular. It was soon recognized that side effects of 
this kind of treatment can be severe. Also the quality of tissues after chemoradiation is 
generally poor. This is an important issue in the treatment of recurrent or residual 
cancers, for the only treatment option is surgery, mostly a total laryngectomy. Chapter 6 
addresses quality of life issues and the complications of surgery after chemoradiation.  
Table 1 Types malignant head and neck tumours 2
Histological type Incidence
Squamous cell carcinoma ± 90% 
Undifferentiated carcinoma 
Lymphepithelioma
Adenocarcinoma 
Adenoid cystic carcinoma 
Mucoepidermoid carcinoma 
Malignant mengtumor 
Malignant melanoma 
Lymphoma
Esthesioneuroblastoma
Sarcoma   
± 10% 
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Chapter II 
Partial laryngectomy for recurrent glottic carcinoma after radiotherapy 
A.Sewnaik, CA Meeuwis, TH van der Kwast, JDF Kerrebijn 
Head and Neck. 2005; 27: 101-107 
Abstract
Background: Early laryngeal cancer is treated with surgery or radiotherapy. 
A partial laryngectomy instead of a total laryngectomy can be used for treating 
radiation failures. 
Methods: Patients were grouped in the two types of partial laryngectomies we perform: 
group I, endoscopic laser surgery (n = 42); and group II, frontolateral partial 
laryngectomy (n = 21). 
Results: With CO2-laser treatment, 14 of 24 patients (no involvement of the anterior 
commissure) and eight of 18 patients (involvement of the anterior commissure) were 
cured. With the frontolateral partial laryngectomy we achieved local control in 15 of 21 
patients.  
Conclusions: If the surgeon is familiar with the different techniques of, and indications 
for, partial laryngectomy, this can be a good and satisfying treatment in selected 
patients radiation failure for glottic cancer. 
Keywords: glottic recurrent laryngeal cancer, radiotherapy, partial laryngectomy, 
endoscopic laser surgery and frontolateral partial laryngectomy 
Introduction
Early laryngeal cancer is curable with either radiotherapy or surgery.1 The aim of the 
treatment is tumour control with maximal preservation of function.2 In most centres in 
Northern Europe and North America, radiotherapy is the primary treatment of small 
laryngeal tumors.3 The main argument for the choice of this kind of treatment is the 
supreme post-treatment quality of voice. 1,4,5 Local recurrences after radiotherapy for 
glottic lesions occur in 5%-20% for T1 tumours and 25%-30% for T2 tumours.6 Once a 
recurrence is confirmed by histological examination, a surgical salvage procedure is the 
only chance of cure. This can be either a total laryngectomy, or a partial laryngectomy, 
the latter through an external approach or an endoscopic (laser) procedure. A total 
laryngectomy is often performed because a wide surgical margin can be obtained, while 
modern speech prostheses allow an adequate functional rehabilitation. However, in 
selected patients, sufficient surgical margins can be obtained with a partial 
laryngectomy, so that these patients retain their own, functional larynx. Unlike total 
laryngectomy, a partial laryngectomy is not a defined operation but merely a common 
denominator for a variety of procedures all aimed at preserving part of the larynx.  
These procedures include endoscopic laser resection, horizontal (supraglottic partial 
procedures), vertical (hemilateral, frontolateral) partial laryngectomy, and supracricoid 
procedures (cricohyoidoepiglottopexy, cricohyoidopexy). The goal of this study was to 
review the oncological and functional results, the indications, and the complications of 
various partial procedures for glottic recurrences after radiotherapy. 
Material and methods 
Between 1980 and August 2002, 63 partial laryngectomies were performed at the 
department of Otolaryngology Head and Neck Surgery of the Erasmus Medical Centre 
Rotterdam in the Netherlands for recurrent (after previous radiotherapy) or second 
primary carcinomas of the larynx. Previous treatment had consisted of radiation of 66 to 
70 Gy, in 2 Gy fractions, five to six times per week. The patients were grouped according 
to the 2 types of partial laryngectomies we perform: group I, endoscopic laser surgery  
(n = 42); and group II, frontolateral partial laryngectomy (n = 21). Before1997, most 
patients were treated with laser surgery, because external procedures were not routinely 
performed during this period. The medical records were studied for oncologic and 
functional follow up, post-operative complications, length of rehabilitation, and other 
clinical information. From 1997 forward, both operative reports and information 
concerning rehabilitation were recorded on standard forms. Patients treated with a 
frontolateral laryngectomy received a questionnaire to assess swallowing and difficulties 
with there voice. These questionnaires were sent out at least 3 months after surgery.  
All recurrent tumours were squamous cell carcinomas except for one undifferentiated 
carcinoma. Routine work-up prior to salvage surgery consisted of a chest x-ray and an 
ultrasonography of the neck, if indicated, combined with fine-needle aspiration.  
CT scans of the larynx were performed only in a minority of patients. 
Group I, CO2-laser surgery (n = 42). 
The indications for laser surgery are listed in table I. The intent of the procedure was 
cure of disease in all patients. The group consisted of 40 men and two women, ranging 
from 45 to 79 years of age. The primary tumour had been classified as Tis in four 
patients, T1 in 34 patients and T2 in four patients. Thirty-five patients had a recurrent 
glottic tumour, and seven patients had a second primary glottic laryngeal tumour.  
The period of recurrence after radiation therapy ranged from 5 months to 14 years. 
Surgery was carried out under general anaesthesia using high frequency jet ventilation.7
Face and eyes of the patient are protected from laser reflections with wet gauze.  
The tumour is excised using laser settings between 5 and 10 Watts at an intermittent or 
continuous pulse. Frozen sections are not routinely used for reasons to be discussed later. 
Antibiotics are not given unless a significant amount of cartilage is exposed. 
Postoperatively, oral feeding is started immediately, and the patient is usually 
discharged the day after the operation. 
Group II. Frontolateral laryngectomy (n =21) 
Indications for frontolateral laryngectomy are listed in table II. All patients were men, 
with an age range of 48 years to 94 years. The primary tumour had been classified as Tis 
in two patients, T1 in 12 patients and, T2 in seven patients. Nineteen patients had a 
recurrent glottic tumour, and two patients had a second primary glottic laryngeal 
tumour. 
The period of recurrence after radiation therapy ranged from 4 months to 32 years.  
The technique of a frontolateral laryngectomy is described by Weinstein and 
Laccourreye.8 It must, however, be kept in mind that after radiotherapy, the tissues are 
more susceptible to oedema and necrosis, and some modifications are necessary. Briefly 
the procedure is as follows. The patient is started on antibiotics (amoxicillin clavulanate 
potassium, 1.2 g three times per day for 1 week). Before the operation, an endoscopy is 
performed. To judge accurately the distal extend of the tumour in relation to the cricoid, 
which is the caudal limit of the resection, a needle may be brought into the larynx 
through the skin over the cricoid cartilage. After a tracheostomy, a midline approach of 
the larynx is made. The outer layer of the perichondrium is elevated from the cartilage 
on both sides but is left attached to the inner side of the thyrohyoid muscle for in 
previous radiated patients the perichondrium is useless for reconstruction as a separate 
layer. A paramedian cartilage cut is made on the lesser-involved side, and the larynx is 
opened through the paraglottic tissues and vocal cord. The second cartilage cut is made 
with direct view of the tumour, and the resection is completed. Frozen sections are taken 
from the wound edges. As much bare cartilage as possible with exception of the 
arytenoids, to reduce the risk of airway obstruction, is covered. The remaining strap 
muscles are used to cover the defect and the skin is closed leaving a suction drain.  
A nasogastric feeding tube is left behind. Postoperatively, oral feeding is started at day 
7; the tracheostomy is also removed at that time if this is considered safe. 
Results
Group I, CO2-laser surgery.  
Results are summarized in table III. Forty-two patients were treated with laser surgery 
for recurrent disease after radiotherapy. Follow-up after first laser surgery ranged from 
17 months to 215 months (average 77 months). Although strictly a contraindication for 
laser surgery, 18 patients had tumour extending into the anterior commissure. The 
reason for this was before 1997, an external procedure was not offered, and patients 
refused a total laryngectomy for relatively small tumours. A total of 42 patients were 
treated with laser surgery. After first laser surgery, 20 patients developed a recurrence, 
and 22 patients remained tumour free after one or two laser procedures. In 24 cases, the 
patients met the criteria (table 1) strictly (no extension of tumour in the anterior 
commissure). Fourteen patients were cured with one laser treatment and 10 patients 
developed a recurrence. One patient with a second recurrence was cured with a second 
laser treatment and, the other nine were managed with a total laryngectomy. One 
patient had a recurrence after total laryngectomy and died of his disease. The recurrences 
occurred between 1 to 48 months after laser treatment (average, 13 months). It must be 
noted, however, that although the criteria for laser surgery were met in this group of 
patients, a number of them would have currently been treated through an external 
approach, mostly because of tumour volume.
In the subgroup of patients (n=18) with tumour extending into the anterior commissure, 
eight patients were cured with one or more laser procedures; 10 patients went on to have 
a total laryngectomy for a new recurrence 
Complications 
Two patients with tumour extending in the anterior commissure had a chondritis of the 
thyroid cartilage develop. One patient was successfully treated with antibiotics and the 
other required surgical intervention; both patients retained their larynx.  
No other complications were seen. 
Functional follow up 
There were no functional problems observed in this group. None of the patients needed a 
tracheostomy or a nasogastric tube. Most of the patients left the hospital the day after 
the operation. 
Group 2, Frontolateral partial laryngectomy 
Results are summarized in table IV. Twenty-one patients were treated with a 
frontolateral procedure. Follow up ranged from 16 to 62 months (average, 41 months). 
One patient was treated with a total laryngectomy 2 weeks after the partial 
laryngectomy because of residual tumour in the operative margins on final pathologic 
examination, although peri-operative frozen sections had been negative. Another patient 
was converted to a cricohyoidoepiglottopexy (CHEP) in the direct postoperative period 
for the same reason. Another patient was treated with a total laryngectomy after 6 
weeks because of a non-functional larynx. Only three patients had a recurrence, 4 to 5 
months after surgery. They were successfully treated with a total laryngectomy  
(10 months - 3 years follow up). Twelve patients are still alive with no evidence of disease 
after a frontolateral laryngectomy. One patient died of heart failure 1.5 years after the 
operation, with no evidence of disease at time of death. One patient died 4 weeks after 
the operation due to heart failure after a period of severe untreated dyspnoea.  
Two patients had a neck recurrence, one in level 2 and the other in level 6.  
One patient chose not to be treated and died with the recurrence.  
The other patient is still alive with no local recurrence.     
Complications 
In the direct postoperative period, we had one case of postoperative haemorrhage.  
One patient suffered from a postoperative pulmonary infection, which was treated with 
antibiotics. Two patients developed a laryngeal-coetaneous fistula, which closed 
spontaneously within 3 weeks of conservative treatment.  
The long-term complications (after 3 months) encountered in a total of six patients were 
persistent dyspnoea (n = 5) and cartilage necrosis (n = 3). Dyspnoea was mainly caused 
by oedema, and was treated with one or more laser procedures (table V). In two patients, 
a permanent tracheostomy remains due to secondary fibrosis of the larynx. All cases of 
cartilage necrosis were successfully treated by minor sequesterostomy and antibiotics.  
Functional follow-up 
Postoperatively, the tracheostomy was removed after 5 to 26 days (median 10 days).  
In two patients the period of tracheostomy was prolonged (45 and 58 days) because of a 
laryngeal coetaneous fistula and dyspnoea. The nasogastric feeding tube was removed 
after 12 days (range, 1-34 days). All the patients resumed an non-restricted full oral diet 
within days of removal of the feeding tube. The average length of the hospital stay was 
twelve days (range, 7-28 days). With a questionnaire, we investigated whether the 
patients were satisfied with there voice after the operation. Fourteen patients were 
satisfied with their voice and suffered no social inconvenience. Only one patient with a 
whispering voice was not satisfied. All patients had a non-restricted full oral diet.  
(table VI) 
Discussion
The standard treatment for recurrent glottic carcinoma after radiotherapy is a total 
laryngectomy. This study shows, however, that in selected cases, a partial procedure is 
safe and effective. In our clinic, laser surgery, frontolateral partial laryngectomy, and 
CHEP are the main partial procedures performed after radiation failure. Selection of 
patients and choice of the right procedure are the key issues. A guideline is presented in 
figure I. 
In the period of 1980-1996, 42 patients with a glottic recurrence were treated with CO2-
laser. This is a relatively small group, but recurrences after radiotherapy for T1 or T2 
glottic tumours occur in only 5% to 20% and 25% to 30% 6,9 respectively, and only a 
small portion of these qualify for laser surgery. Although the results of primary 
treatment of small glottic carcinoma with CO2-laser surgery are well documented,10-13 few 
reports deal with laser treatment of recurrent glottic carcinoma after radiation therapy. 
If the criteria were strictly met, in our study more than 52% of the patients retained 
their larynx when treated by laser surgery. Only one patient in this group died of disease 
after total laryngectomy for a further recurrence, suggesting that little or no extra risk is 
involved for the patient. Our results are similar to those of CO2-laser treatment of 
recurrent glottic carcinoma reported in the literature. Blakeslee et al 14 reported a 40% 
success rate and thinks that extension of the tumour into the anterior commissure is a 
contraindication for laser surgery. Casiano et al 15 found a 5-year cure rate of 51% in 
previously irradiated patients, and the success rate was reduced (45% vs. 65%) if the 
anterior commissure was involved. Outzen and Illum 16 reported similar results. After 
salvage procedures, a 5-year cure-rate of 98% was achieved. All these reports deal with 
small a small number of patients, all groups being smaller than 20. Most authors regard 
extension of the tumour in the anterior commissure a contra-indication to laser surgery. 
Like Casiano et al 15 we found a higher recurrence rate in anterior commissure 
involvement (67% vs. 42%) and nearly 60% of these patients finally underwent a total 
laryngectomy (the others could be salvaged with another partial procedure). 
If the tumour extends in the anterior commissure survival is not compromised; however 
70% loose their organ due to a new recurrence. These findings firm our opinion that 
extension into the anterior commissure is a contraindication to laser surgery, and we, 
therefore, recommend an external procedure. However in patients with poor general 
health, laser surgery can still offer a good alternative, because of the short surgical time, 
few complications, and fast rehabilitation. In the frontolateral partial laryngectomy 
group, we found a control rate of 71%. This is consistent with the literature. Kooper et al 
17 found an oncologic control rate of 88%. Other studies report control rates of between 
70 and 100%. 5,18-21  Rehabilitation after frontolateral partial laryngectomy was 
generally rapid; most patients left the hospital within 2 weeks of the operation on a full 
oral diet with the tracheostomy removed. Complete endolaryngeal wound healing was 
never completed at that time and was frequently observed to take up to 3 months. 
Complications were few and well manageable in our series, but the two main concerns 
after a frontolateral procedure are cartilage necrosis and airway problems.  
Modification of the surgical technique can mostly prevent these problems. 
In the patients that suffered from cartilage necrosis, a substantial area of cartilage had 
been left uncovered during surgery. Hardillo 22 has shown that healing of bare cartilage 
has a risk of forming granulation tissue and scar tissue. Therefore, covering the bare 
cartilage is strongly recommended. For this purpose we prefer to fold the thyro-hyoid 
muscle with the outer layer of perichondrium attached to it around the remaining 
cartilage. If all the cartilage cannot be covered, the cartilage may serve as a stent and 
can easily be removed at a later stage if necessary, but repeat endoscopies may be 
required to remove granulations and assess tumour control in the meantime. As in 
supraglottic laryngectomy,23 denuded cartilage of the arytenoids should however not be 
covered, because local oedema at the widest part of the larynx will compromise the main 
airflow. A false vocal cord may be used to reconstruct a vocal cord and/or cover cartilage. 
For the reason mentioned above this should only be carried out unilaterally. 
We investigated the subjective feelings of the patients about the voice and swallowing by 
means of a questionnaire. Except for one patient, all were satisfied with their voice. They 
did not have any social inconvenience of their voices. All our patients have a normal diet 
without any restrictions. Other authors 18,19 also report satisfactory speech and 
swallowing. An alternative for recurrent laryngeal cancer is a CHEP. This procedure is 
performed in patients with a bulky tumour or extension in one of the arytenoids. We 
have performed 11 CHEPs with satisfactory functional results, but these are not 
reported due to short follow up. In partial laryngectomy procedures, the resection 
margins cannot be as wide as in total laryngectomy. The use of intraoperative frozen 
sections is the key to maximum safety. It must be kept in mind that a frozen section of 
post-irradiation tissue is difficult to examine, and stellate shaped growth or perineural 
growth may be missed. The pathologist should be aware that a good orientation of the 
resection margin in the frozen section is of utmost importance, allowing the microscopic 
examination of the full length of the surface lining epithelium. Failure to achieve this 
may lead to a false-negative outcome. Diagnostic pitfalls can be squamous cell 
metaplasia of subepithelial laryngeal glands and ducts. Particularly, necrotizing sialo-
adenitis may be confused with squamous cell carcinoma leading to a false-positive report. 
Distinguishing between dysplasia and carcinoma in situ from irradiation related atypia 
of the lining epithelium might also be difficult in frozen sections. Furthermore, 
inflammation caused by previous radiotherapy makes the interpretation of frozen 
sections of the margins difficult. It is extremely important to prepare the patient 
beforehand, not only for conversion to a total laryngectomy during surgery, but also for 
the possibility of a re-operation in the direct postoperative phase. Because of the often 
tight resection margins and to facilitate maximum orientation, frozen sections should be 
taken from the wound, not from the specimen. The difficult interpretation of the frozen 
margins is one of the reasons surgeons may decide not to perform partial laryngectomy 
in radiation failures.17, 24 The main reasons for us not to routinely perform frozen sections 
during laser surgery are that the laser evaporates the margin and adds a factor of heat 
damage. It is also more difficult to obtain adequate tissue from the wound for frozen 
section.
Conclusion
In conclusion, if the surgeon is familiar with the different techniques of, and indications 
for, partial laryngectomy, this can be a good and very satisfying treatment in selected 
patients with glottic cancer who had radiation fail. On the other hand, if the patient or 
procedure is not selected carefully, this may lead to disaster, and patients should be 
mentally capable of coping with a possible conversion to total laryngectomy 
perioperatively or postoperatively.  
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Table I   
Indications for CO2-laser surgery. 
 Limitation of the tumour to the glottis 
 Limited supraglottic extension 
 No subglottic extension 
 Normal mobility of both vocal cords 
No extension in the anterior commissure 
Complete endoscopic tumour visualization 
Table II 
Indications for the frontolateral partial laryngectomy  
 Tumour limited to the glottis 
  Limited supraglottic extension 
  Limited subglottic extension (1cm) 
 Extension in the anterior commissure 
 Normal vocal cord mobility 
 No cartilage involvement 
 No arytenoids involvement 
Table III Results of CO2-laser treatment 
Involvement of 
anterior commissure 
N CO2-laser 
successful 
Salvage total 
laryngectomy after 
CO2-laser failure 
Failure of salvage 
total laryngectomy 
No involvement  
Involvement
24
18
14
8
9
8
1
2
Table IV Oncologic follow-up frontolateral partial laryngectomy 
Disease free 
Post-operatively converted 
Recurrence
15
3
3
*: In 3 patients there was no evidence of disease at time of death. 
Table V  Number of and the reason for endoscopies frontolateral partial 
laryngectomy 
Dyspnoea 
Granulation tissue     
Recurrent
8
3
3
Table VI Functional results after frontolateral partial laryngectomy 
Airway
Swallowing 
Speech
N=13 no airway problems 
N= 2 permanent tracheostomy 
All patients (N=15) have a non-restricted full oral diet 
N=14 satisfied with their speech 
N=1 whispering voice 
Figure 1 
Guideline for selection of patients and choice of the right procedure.  
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Abstract
Background: Recurrent laryngeal cancer can either be treated with a total laryngectomy 
or in selected cases with a supracricoid laryngectomy with cricohyoidoepiglottopexy 
(CHEP).
Objective: To analyze the functional and oncological results of the supracricoid 
laryngectomy with CHEP. 
Study design: Retrospective study 
Methods: Fourteen patients were treated with a supracricoid laryngectomy with CHEP.  
In 8 patients a flexible endoscopic evaluation of swallowing was performed. Pre-and 
post-operative voice evaluation was performed in 5 patients. Oncologic and functional 
follow up, post-operative complications, and data concerning rehabilitation were 
recorded on standard forms 
Results: After the supracricoid laryngectomy with CHEP, 11 out of 14 patients are alive 
and disease free. No local recurrences were found, but 2 had regional recurrences. The 
voice is worse after the operation; however, most patients are satisfied. Swallowing was 
uncompromised. 
Conclusion: Supracricoid laryngectomy with Cricohyoidoepiglottopexy (CHEP) for 
recurrent glottic laryngeal cancer after radiotherapy appears to be oncologically safe and 
functional. 
Keywords: cricohyoidoepiglottopexy, recurrent glottic cancer, voice, swallowing   
Introduction
Recurrent laryngeal cancer can either be treated with a total laryngectomy or in selected 
cases with a partial laryngectomy. A partial laryngectomy is unlike a total 
laryngectomy, not a well-defined operation but a term nominating a variety of 
procedures all aimed at preserving part of the larynx. These procedures include 
endoscopic laser resection; horizontal partial laryngectomy (supraglottic partial 
procedures); vertical (hemi-, fronto-lateral) partial laryngectomy; and supracricoid 
procedures (cricohyoidoepiglottopexy, cricohyoidopexy). The three techniques most 
commonly used by us in case of recurrent laryngeal cancer are CO2 laser surgery, 
frontolateral partial laryngectomy and supracricoid laryngectomy with 
cricohyoidoepiglottopexy (CHEP). The first two procedures were reported in an earlier 
paper.1 This paper addresses the third technique, the supracricoid partial laryngectomy 
with cricohyoidoepiglottopexy (CHEP).   
The supracricoid laryngectomy with CHEP is mostly used for treatment for selected 
primary glottic laryngeal cancers.2-5 The goal of this technique is a total removal of the 
tumour, while creating a new functional larynx, which is adequate for swallowing and 
speaking.  
The oncologic results after the supracricoid laryngectomy for primary laryngeal cancer 
are good. The reported 5-year survival in the literature varies from 84% to 96%.2,4,6,7 
There are not many studies 8,9,10 reporting results of the supracricoid laryngectomy for 
treatment of recurrent laryngeal cancer. However, in these studies the reported oncologic 
results are good. The 3-year survival rate in these studies varied from 83% to 100%.  
With this technique the function of the larynx, swallowing and speaking are preserved. 
However, at least some impairment of especially the voice cannot be avoided.   
The voice after the supracricoid laryngectomy with CHEP is always hoarse compared to 
normal speakers. The vocal cords, which are routinely removed during the operation, are 
critical for a high quality of voice.5 The quality of the voice after the supracricoid 
laryngectomy with CHEP also depends on preservation of either one or two arytenoids.  
Swallowing after CHEP treatment for primary carcinoma is generally reported to be 
normal. However, Dworkin et al 11 pointed out that patients who had supracricoid 
laryngectomy required specific swallowing exercises, before the feeding tube safely could 
be removed. There are no data available for patients who had previous radiotherapy. 
This study presents the functional and oncological results of patients treated with a 
supracricoid laryngectomy with cricohyoidoepiglottopexy after radiation failure. 
Material and methods 
Between 2000 and 2004, 14 patients were treated with a supracricoid laryngectomy with 
cricohyoidoepiglottopexy (CHEP) at the department of Otolaryngology Head and Neck 
Surgery of the Erasmus Medical Centre Rotterdam in the Netherlands for recurrent 
glottic carcinoma. None of the patients were treated with a supracricoid laryngectomy 
with cricohyoidopexy (CHP). In all cases the primary tumour had been treated with 
radiotherapy (66 Gy, in 2-Gy fractions, 5 or 6 times per week). The group consisted of 12 
men and 2 women. Ages ranged from 49 to 79 years.  
Oncologic and functional follow up, post-operative complications, and data concerning 
rehabilitation (duration of tracheostomy and nasogastric tube) were recorded on 
standard forms. Information concerning location, TNM classification and radiation dose 
of the primary tumours are listed in table I. Routine work-up prior to salvage surgery 
consisted of a chest X-ray and an ultrasound of the neck, if indicated, combined with 
fine-needle aspiration. Only in selected cases a CT scan was performed.   
Supracricoid laryngectomy with Cricohyoidoepiglottopexy
Indications for supracricoid laryngectomy with CHEP after previous radiotherapy are 
listed in table II. If the recurrent tumour is limited to the vocal cords with little supra- or 
subglottic extension, normal vocal cord mobility and extension in the anterior 
commissure an external frontolateral partial laryngectomy can be performed. A 
supracricoid laryngectomy is treatment of choice if extension into the paraglottic space is 
suspected or there is tumour spread onto the mucosa of one of the arytenoids. Another 
reason to consider a supracricoid laryngectomy is a pre existent narrow airway due to 
anatomy (females) or oedema. 
The procedure has extensively been described elsewhere,12 and differs in previously 
irradiated patients only in a few details different from primary procedures. After an 
endoscopy the supracricoid laryngectomy is started with an apron like incision of the 
skin after which skin-platysma flaps are raised. The strap muscles are divided in the 
midline, detached from the hyoid bone and retracted laterally. The superior laryngeal 
arteries and veins are ligated, but the nerves are preserved. The thyroid isthmus is then 
divided and the thyroid lobes are partially separated from the trachea, taking care not to 
damage the recurrent nerves. A downward blunt dissection of the trachea is performed to 
permit upward displacement at the time of closure. This part of the operation is different 
for irradiated patients. In previous irradiated patients, there is more fibrosis and the 
trachea must be mobilized deeper into the thorax, however in some cases this might not 
even be enough for a tensionless closure of the pexie. The constrictor muscles are 
separated from the thyroid cartilage and the pyriform sinuses are mobilized. The larynx 
is entered between the thyroid cartilage and hyoid bone, going through the base of the 
epiglottis and through the pre-epiglottic space. A second entrance is made by an incision 
through the cricothyroid membrane. At this time the orotracheal tube is removed and 
inserted through the inferior incision. The thyroid is mobilized from the cricoid by 
disarticulation from the thyrocricoid joints, or by cutting the inferior horns of the 
thyroid cartilage, which reduces the chance of damaging the recurrent laryngeal nerves. 
From superiorly and with the tumour in view, the entire thyroid cartilage with both 
vocal cords, including the tumour, are removed. At least one, but preferably both, 
innervated arytenoid complexes are left. Frozen sections are taken from the wound 
edges. After approximation of the cricoid and hyoid, the level of the tracheotomy can be 
established and a tracheotomy is performed. To facilitate swallowing, the bases of the 
arytenoids are sutured downwards and medially, and a suspension suture is put through 
the pyriform sinus on either side that will be cross-tied after final approximation of the 
cricoid to the hyoid. Three zero silk or vicryl sutures are placed around the cricoid and 
hyoid, one in the midline and the others 1cm to either side. These are used to bring these 
structures together. Coming around the hyoid, the sutures should also be looped through 
the base of tongue for better positioning of the larynx. If the cricoid and hyoid cannot be 
brought together tensionless, which is essential in irradiated patients, partial release of 
the hyoid bone from the muscles of the floor of the mouth and especially detachment of 
the stylohyoid ligament can be performed. This is usually not necessary, and even 
contraindicated in primary procedures. The strap muscles are sutured together and the 
skin is closed leaving a suction drain.  Contrary to primary supracricoid procedures, in 
previously irradiated patients we prefer to continue antibiotics (Amoxicilline 
Clavulanate Potassium, 3 daily doses of 1.2 g for 1 week, followed by 3 daily doses of 625 
mg) post-operatively for 4-6 weeks, because of delayed wound healing. 
Flexible endoscopic evaluation of swallowing (FEES) 13
At least 3 months after the operation swallowing was evaluated in 8 patients. A 
thorough history of swallowing was obtained and a FEES was performed. 
A speech pathologist and the author performed the FEES. Equipment necessary to 
perform a FEES includes a flexible fiberoptic endoscope (Pentax Medical Company, 
Montvale, New Jersey) attached to Alphatron Stroboview 2000 (Alphatron Medical 
Systems, Rotterdam), which consist of a light source, a digital camera and a monitor and 
was used for recording. For the endoscopic evaluation, the patient was positioned seated 
upright in a chair. The flexible endoscope was inserted via the nose and advanced until 
the tip was in the oropharynx. From this point, the management of colored water, 
yoghurt and crackers was assessed. The items scored with the FEES were: premature 
spillage of material, pharyngeal residue of material, penetration and aspiration. After the 
FEES a form with the above mentioned points were filled in.  
Evaluation of the voice 
Five patients underwent pre- and post-operative voice evaluation. This was performed 
by the speech pathologist. 
Recordings were made in a quiet room on a Sony Digital Audio Tape recorder (DTC-
57ES) (Tokyo, Japan) with a Sennheiser microphone (BG 2.0 dynamic) (Wedemark, 
Germany). The distance between the patient (mouth) and microphone was 30 cm. 
Intensity and frequency measurements were obtained with an automatically recording 
phonetograph (Pabon/Laryngograph 1997, London, England). The Multi-Speech 
program (Kay Pentax, Lincoln Park, New Jersey) was used for calculating Harmonics to 
Noise Ratio (HNR). A stopwatch was used for measuring the maximum phonation time. 
The following measurements of the voice were performed: 
1. Perceptual Voice Analysis 
Recordings were made of a short reading text and a short sample of conversational 
speech. The samples were evaluated by another, independent, speech pathologist. The 
pre- and postoperative samples of one patient were played in random order. The 
hoarseness of the voice quality was evaluated and the voices were compared and judged 
as better, worse or the same. 
2. Maximum Phonation Time (MPT)
The subjects were asked to inhale deeply and sustain an /a/ for as long as possible at a 
comfortable pitch and loudness. This was recorded three times; the longest phonation 
time was used.  
3. Harmonics to Noise Ratio (HNR)
The subjects phonated on /a/ at a comfortable pitch and loudness during approximately 
3 seconds. The HNR were calculated on a sample of one second, starting half a second 
post voice onset.  
4. Intensity and frequency measurements 
If possible a phonetogram was made.14
Results
Fourteen patients were treated with a supracricoid laryngectomy with 
cricohyoidoepiglottopexy. Six patients also underwent a selective neck dissection  
(levels 2,3,4).  
The follow-up period is on average sixteen months (range 3-41 months). In total eleven 
patients are still alive and are disease-free. (Table III) Local recurrences have not 
occurred in any of the patients so far. Two patients developed a regional recurrence in 
the neck. The first patient had a neck recurrence 8 months after the operation. He chose 
not to be treated and died 3 months later. The second patient had the recurrence after 3 
months and a neck dissection was performed. In the same patient a pulmonary 
metastasis was discovered 9 months after the supracricoid laryngectomy with CHEP and 
died 3 months later. 
One patient died 5 months after the operation due to heart failure.  
At time of death, he was disease free. 
The average length of the hospital stay was eighteen days (range 11-35 days).
Postoperatively, the tracheostomy was removed after 12 to 365 days (median 74 days). 
The reason for this is that in previous irradiated patients the wound healing is delayed 
sometimes resulting in late airway obstruction due to oedema or infection. We 
experienced this in patients treated with the fronto-lateral partial laryngectomy.1 The
canula is mostly corked after one week. On average, the nasogastric feeding tube was 
removed after forty-five days (range 10-120 days). During this period the patients 
followed an intensive swallowing rehabilitation program supervised by an experienced 
speech-swallowing pathologist. However, all patients went on to a non-restricted full oral 
diet before removal of the feeding tube.  
In the direct postoperative period, we had one case of postoperative haemorrhage. One 
patient suffered from a postoperative pulmonary infection, which was treated with 
antibiotics. One patient, who also had a poor pulmonary status and did not understand 
the rehabilitation instructions, had a total laryngectomy because of severe aspiration 
after three months. Long-term complications were seen in three patients. Two patients 
suffered of dyspnoea due to oedema. Both patients were treated with laser surgery. Both 
patients had a prolonged temporary tracheotomy. The tracheostomies were removed 
after 12 months.  In one patient granulation tissue imposing as tumour was seen at the 
pexie.  This was felt to be due to the use of PDS sutures instead of vicryl for the pexie 
site.
Eight patients were evaluated for post-operative swallowing function. The period 
between the operation and the evaluation ranged from 2 to 40 months (average 18 
months). One patient had recently undergone hip surgery and was not able to visit our 
clinic during the study. The other patient recently had CO2 laser surgery (see above) of 
the larynx for oedema.  
All patients questioned were on a non-restricted oral diet. Two patients mentioned 
regular aspiration. Four patients had aspiration sometimes, and 2 patients say they 
never aspirated. Of the patients aspirating, 3 aspirated while drinking fluids and 3 after 
eating solids. With the FEES, we could not confirm aspiration of solids or fluid in any of 
the patients. After swallowing colored water, 1 patient had residual in the pharynx. This 
was gone after swallowing once more. After eating yoghurt residual in the pharynx was 
seen in 4 patients. Also after swallowing once more, the residual was gone in all patients. 
After eating a cracker, only in 1 patient had residue in the pharynx. In none of the 
patients was penetration or aspiration seen after ingestion of water, yoghurt or crackers. 
These results are shown in table IV. 
Eight patients are subjectively satisfied with there voice. Two patients with a whispering 
voice are dissatisfied. Five patients had pre- and post-operative evaluation of the voice. 
The results are listed in table V. One patient had such a poor voice after the operation 
that the measurements could not be performed. 
The harmonics noise ratio was also worse in three patients after the operation.  
The perceptual voice analysis was worse after the operation in all the patients.  
The maximum phonation time was worse in 2 patients. Intensity and frequency 
measurements (phonetograms) were not possible because of the poor voice quality. 
Discussion
The gold standard treatment for recurrent glottic carcinoma after radiotherapy is a total 
laryngectomy, however in selected patients a partial laryngectomy may be considered. 
Besides CO2-laser resection and fronto-lateral partial laryngectomy,1 supracricoid 
laryngectomy with cricohyoidoepiglottopexy (CHEP) was shown to be a reliable 
treatment method as long as the indications are respected. Besides the criteria as listed 
before, other factors especially pulmonary status and diabetes play an important role in 
the decision if a supracricoid laryngectomy with CHEP may be performed.  The patients 
should have a relatively good general condition. Prior to the operation all patients are 
informed about the relatively long rehabilitation period. Before the operation it should 
also be discussed with the patient that during the procedure a conversion to a total 
laryngectomy may be necessary if the tumour turns out to be too extensive or if the 
frozen section of the margins are positive. It is very important is that the patients 
understand and agree with this. 
The follow up in our study is relatively short but so far we have seen no local recurrences. 
The disease free survival in the literature of the supracricoid laryngectomy with CHEP 
after radiotherapy vary from 83-100%.8-10 But also in these studies the follow-up period 
is also relatively short ( 36 months 10) and the patient groups are small. The largest group 
was fifteen patients.10 This is understandable because the selection criteria for the 
supracricoid laryngectomy after irradiation failure are strict and should be followed 
without concessions. 
The technique 12 of the supracricoid laryngectomy is not very different in case of 
previous radiotherapy. The main difference lies in the superior relaxation of the hyoid 
bone, which may be necessary to obtain tensionless closure and a long continuation of 
antibiotics. In this study decannulation was performed on average after 45 days. In most 
studies decanulation was performed earlier. We left the tracheostomy for a longer period 
of time for safety purposes, because of the delayed wound healing and the vulnerability 
to infections after radiotherapy. 9 Lacourreye et al 9 described increased duration of 
tracheostomy after supracricoid laryngectomy in previous irradiated patients. The 
increased duration was related to significant postoperative oedema at the level of the 
remaining arytenoids cartilage and the healing delay induced by radiotherapy.  
The canula is closed off generally after one week but left in situ to minimize the risk of 
acute airway obstruction due to oedema caused by inflammation. A rule of thumb is that 
80% of wound healing is completed before the tracheotomy is removed. 
After supracricoid laryngectomy with CHEP patients retain all normal laryngeal 
functions. However the quality of voice is negatively affected by the operation. After the 
supracricoid laryngectomy vibrating mucosa on the anterior surface of the arytenoids 
generates the voice. If one arytenoid is present, the mucosal wave can be seen between 
the mucosa of the arytenoids and the epiglottis. If both arytenoids are present, the 
mucosal wave is seen between the arytenoids and between the arytenoids and the 
epiglottis.5 The voice is evaluated with questionnaires and objectified with 
measurements such as maximum phonation time. Spriano et al 10 evaluated the voice by 
measuring the maximum phonation time ( 3 to 18 s; mean: 8,3 s) and found this to be 
shorter comparing it to normal adult speakers.  
We have made an attempt to qualify loss of voice in this study. Our study, using 
perceptual voice analysis, confirms that the quality of the voice is worse than before 
after supracricoid laryngectomy with CHEP in most cases. However, the perceptual 
voice analysis is limited with one evaluator and this might be a potential weakness of 
this study. The maximum phonation time we found varies from 6 to 16s (normal: 19s); 15
which was also found by Spriano.10 The negative value of the harmonics to noise ratio 
(more noise than harmonics) also indicates a relatively poor voice. One could expect that 
most patients experience difficulties while speaking and would therefore be dissatisfied 
with their voice, however most patients in this study are subjectively satisfied with their 
voice. An explanation could be that most patients are elderly and do not use their voice 
professionally. None of our patients complain problems of swallowing. At the time of 
assessment all patients were on a non-restricted oral diet. However, all but one patient 
had a long swallowing rehabilitation period after the operation. The nasogastric tube was 
removed after an average of 45 days. Most studies addressing supracricoid laryngectomy 
with CHEP as primary treatment 11,16 reports an earlier removal of the nasogastric tube 
(average 23 days). However, all patients needed an extensive swallowing rehabilitation 
program supervised by a speech pathologist. The longer after the operation, the better 
the swallowing gets. None of the patients mentioned aspiration on a regular base, which 
was confirmed by FEES. This is an encouraging fact, but we should keep in mind that 
most patients were studied after a relatively long period postoperatively. Dworkin et al 11
also performed FEES after the supracricoid laryngectomy with CHEP with worse 
results. He found a moderate degree of premature spillage into the valleculae, chronic 
pooling of food residuals and mucous secretions within the hypopharynx that leaked into 
the larynx. This caused excessive throat clearing and coughing episodes. The reason for 
this might be that they performed the FEES earlier after the operation. 
Also, patients are probably more concentrated on swallowing during FEES and therefore 
a good result might underestimate the reality.  Other studies 16,17 also find good 
swallowing after CHEP.  However, these studies were performed by questionnaires and 
were performed in non-irradiated patients.  
In conclusion, supracricoid laryngectomy with cricohyoidoepiglottopexy for recurrent 
glottic laryngeal cancer after radiotherapy appears to be oncologically safe and 
functional. However, all patients have a prolonged, intensive rehabilitation period and 
therefore not only tumour characteristics, also patient characteristics, should be 
considered before deciding to perform a supracricoid laryngectomy with CHEP after 
radiotherapy.  
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Table I  Patient characteristics (N = 14) 
Localization T stage N stage Radiotherapy 
Glottic: 14 Tis: 1 
T1: 6 
T2: 7 
N0: 14 66Gy: 14 
Table II Indications for the supracricoid laryngectomy with 
 cricohyoidoepiglottopexy (CHEP) 
 Tumour limited to the glottis 
  Limited supraglottic extension 
  Limited subglottic extension (1cm) 
 Extension in the anterior commissure 
 Normal vocal cord mobility 
 Extension into the paraglottic space 
Extension onto mucosa of one of the arytenoids possible 
Table III Oncologic follow up supracricoid laryngectomy 
 with cricohyoidoepiglottopexy (CHEP) 
Disease free and alive 
Post-operatively converted 
Recurrence
10
1
local: 0 
regional: 2 
distant: 1 
Table IV Result of Flexible Endoscopic Evaluation of Swallowing  
 (FEES) 
N = 8 
Water
N = 
Yoghurt 
N =
Cracker
N =
Premature spillage 
Pharyngeal residue
Penetration
Aspiration
0
1
0
0
0
4
0
0
0
1
0
0
Table V Voice Measurements  
N = 5 
HNR (dB) MPT (s) PerceptualPatie
nt pre Post pre post Pre Post
1 -3.14 -0.76 11 16
Moderate to 
severe
hoarseness
Worse, softer, 
weaker
2 -9.05 * 5 *
Moderate to 
severe
hoarseness
Worse,
aphonic 
3 -5.14 -7.65 10 6
Moderate to 
severe
hoarseness
Worse, weaker 
4 -7.75 -11.12 8 8
Severe
hoarseness
Worse, more 
effort,  
5 -3.83 -11.36 8 10
Severe
hoarseness
Worse, weaker 
* Measurements not possible 
Normal values: 
HNR: > 7,3 dB 18
MPT: 19s 15

Chapter IV 
Surgery for recurrent laryngeal carcinoma after radiotherapy: 
Partial laryngectomy or total laryngectomy for a better quality of life? 
A. Sewnaik, JL. van den Brink, MH. Wieringa, CA. Meeuwis, JDF. Kerrebijn, 
Otolaryngology Head and Neck Surgery. 2005; 132: 95-98 
Abstract
Objective: To investigate the quality of life after partial laryngectomy versus total 
laryngectomy for recurrent laryngeal carcinomas after radiotherapy. 
Study design and setting: A retrospective study performed at least one year after  
treatment. This study was performed in a university hospital. 
Results: Twenty-three patients (N=12 partial laryngectomy, N=11 total laryngectomy) 
with recurrent laryngeal cancer after radiotherapy were included in the study. Three 
different questionnaires: (1) EORTC Quality of Life Questionnaire (QLQ) – C30 Dutch 
version 3.0, (2) EORTC – H & N 35 and (3) the Voice Handicap Index, were sent to all 
patients. The only major difference in quality of life of patients after partial 
laryngectomy versus total laryngectomy was found to be smell and taste related.  
No other differences were found. 
Conclusion: We did not find much difference in quality of life after treatment with a 
partial laryngectomy or a total laryngectomy in patients with recurrent laryngeal cancer 
after radiotherapy.  
Introduction
Cancer of the larynx is the most common of the cancers of the head and neck carcinomas 
in the Netherlands. The primary treatment of T1-T3 laryngeal carcinomas is 
radiotherapy, while for T4 carcinomas treatment may either be accelerated radiotherapy 
or surgery combined with radiotherapy, depending on the extent of the tumor.1 The rate 
of recurrences after radiotherapy ranges from 11% to 73% and is strongly dependent on 
the T stage of the primary tumor.2 The gold standard for treatment of recurrent 
laryngeal carcinoma of the glottis after radiotherapy is a total laryngectomy. However in 
selected cases a partial laryngectomy can be performed. In our clinic three different 
partial procedures (endoscopic laser surgery, frontolateral partial laryngectomy, and 
supracricoid partial laryngectomy) are performed as salvage surgery after radiotherapy 
failure.
The treatment of laryngeal cancer has a great impact on a person’s life. In particular, 
total laryngectomy affects crucial functions such as breathing, swallowing, and 
speaking.3
Relic et al 4 described that reactions to illness and treatment not only depend on the 
patient’s physical situation but also vary according to factors such as personality, 
profession, age, cultural environment, and social status, even when patients undergo the 
same treatment and gain similar functional outcome. Patients can show a positive 
attitude towards their illness, while they can suffer greatly from the slightest change in 
their voice. Individuals who use their voice frequently, for example for work, are more 
affected than others after a total laryngectomy. Another aspect that changes after a 
total laryngectomy is the presence of a permanent tracheostoma with mucus visible. 
There is a cosmetic aspect and some activities, such as swimming (and smoking!!),
cannot easily be done. Furthermore, after a total laryngectomy the sense of smell is lost. 
This is different after a partial procedure. However, in our experience a partial 
procedure, especially in case of cricohyoidoepiglottopexy requires a longer rehabilitation 
period, compared to total laryngectomy.5,6
If another treatment modality than the “gold standard” is chosen, the initial debate 
focuses on oncological results of this treatment. Our results7, and those of others, 2,8,9
after a partial procedure for recurrent carcinomas are oncologically satisfactory. Several 
studies 10-12 address the quality of life in patients with primary laryngeal cancer. In these 
studies the quality of life (QoL) after various treatment modalities for primary laryngeal 
cancers, such as radiotherapy, partial laryngectomy and total laryngectomy are 
compared. A better QoL after a partial procedure is found compared to a total 
laryngectomy. Müller et al 10 also found a better QoL both after a partial procedure, and 
after radiotherapy. The patients had a significant better global health status, role and 
social functioning. They did, however, compare QoL between partial laryngectomy and 
other treatment modalities in patients with primary laryngeal cancer. To our knowledge, 
our study is the first that investigates the quality of life after partial laryngectomy 
versus total laryngectomy for recurrent cancer of the larynx. 
Material and methods 
A questionnaire was sent to 34 patients who had been treated for recurrent cancer of the 
larynx. Twenty-three questionnaires were filled in and returned. This group consisted of 
12 patients treated with a partial procedure and 11 patients after a total laryngectomy. 
In the group of partial procedures 7 patients were treated with a frontolateral partial 
laryngectomy and 5 patients with supracricoid partial laryngectomy. Patients were 
treated with a total laryngectomy because they did not meet our selection criteria for a 
partial laryngectomy. These selection criteria are described in another paper.7
Three different questionnaires were sent to all patients: 1) EORTC Quality of Life 
Questionnaire (QLQ) – C30 Dutch version 3.0, 13,14 2) EORTC – Head & Neck (H & N 35) 
15 and 3) the Voice Handicap Index.16
The EORTC QLQ – C 30 13,14 consisted of five functional scales: physical (five items), role 
(two items), emotional (four items), cognitive (two items) and global health status (two 
items); three symptoms scales: fatigue (three items), nausea/vomiting (two items) and 
pain (two items); and six single items: dyspnoea, insomnia, appetite loss, constipation, 
diarrhea and financial difficulties. In total, there were 30 questions. The patients had to 
answer the questions by indicating one of four categories  (1 = not at all, 2 = not much, 3 
= moderate, 4 = very much). Two questions had to be answered on a 7-point scale (1 = 
very bad – 7 = excellent). Higher scores for functional scales represent better quality of 
life. For the symptom oriented scales and items, a higher score corresponds to a worse 
condition.  
The EORTC QLQ – H & N 35 15 is a diagnosis-specific questionnaire for patients with 
head and neck cancer. It consisted of 35 questions concerning problems that are 
attributable to the head and neck cancer and side effects of the treatment. The patients 
had to answer the questions by indicating one of four categories (1 = not at all, 2 = not 
much, 3 = moderate, 4 = very much) as in the EORTC QLQ – C30.13,14  A higher score 
corresponds to a worse Quality of Life. 
The third questionnaire, the Voice Handicap Index, 16 was included to investigate 
speech-related problems. The goal of the Voice Handicap Index 15 is to investigate 
psychosocial problems caused by speech disorders. The Voice Handicap Index 16
consisted of three scales: functional (10 items), emotional (10 items) and physical (10 
items). The patients had to answer the questions by indicating one of five categories (1 = 
never, 2 = nearly never, 3 = sometime, 4 = almost always, 5 = always). A higher score 
corresponds to a more difficulties with the speech. 
Statistical analysis was performed using SPSS. 
Results
The partial laryngectomy group consisted of ten men and two women. In the total 
laryngectomy group, 9 patients were men and 2 were women. The age ranged from 54 
years to 82 years. The questionnaires were sent a minimum of one year after the 
operation.  
Table I shows the results of the EORTC QLQ – C30 13,14 for the two groups. There are no 
statistically significant differences found between the two groups in the several subscales. 
Table II shows the results for the EORTC QLQ – H & N 35 15 for the two groups. A 
statistically significant difference (p = 0.002) was demonstrated between the 2 groups for 
smell and taste related problems in favor of patients after partial laryngectomy (median 
partial 1.0 vs. median in total laryngectomy group 2.5). In Table III the result of the 
Voice Handicap Index 16 is shown. The functional subscale after a total laryngectomy 
(median = 29) did not differ significantly with the group of partial procedures (median = 
22). The same results were found for the other subscales: emotional (median total 24 vs. 
median partial 21.5) and physical (median total 23.5 vs. median partial 24.0).  
Discussion
In this study the only major difference in quality of life of patients after partial 
laryngectomy versus total laryngectomy was found to be smell and taste related. We 
believe that loss of smell has a negative impact on the quality of life, because patients 
enjoy their meal less. However, in this study this does not necessarily mean a loss of 
appetite (Table I). Other studies 10,11 found that patients after a total laryngectomy 
experienced more trouble with eating. However, both studies do not specify the 
problems.
We had expected a difference in acceptance of someone’s appearance between the two 
groups, but this could not be demonstrated. An explanation might be that patients have 
accepted their new appearance with passing of time, surgery being at least one year 
previously. Also, no difference could be demonstrated with regard to speech related 
problems, as analyzed with the Voice Handicap Index. 16 All patients were reasonably 
satisfied with their speech after the operation. In other studies 11 a better voice-related 
quality of life after a partial procedure was found.  
Several studies 10,11 found a significant better quality of life (voice related, physical, 
mental) in patients with a preserved larynx. Müller et al 10 compared five different 
treatment modalities (chordectomy, partial laryngectomy, radiotherapy, total 
laryngectomy and total laryngectomy with radiotherapy) in patients with a primary 
cancer of the larynx. They found a poor quality of life after total laryngectomy (with or 
without radiotherapy) compared to radiotherapy alone or a partial procedure. However, 
selection bias might have influenced their results, but they did not mention the disease 
stages of the different groups. One could expect that disease stage might influence 
outcome. Weinstein et al 11 found a better quality of life after a supracricoid partial 
laryngectomy compared to a total laryngectomy as primary treatment. Here also, a 
difference in disease stage might cause a bias in the results, for most patients treated 
with a supracricoid partial laryngectomy were staged as T1 or T2, while in the total 
laryngectomy group most patients were staged as T3 or T4. Smith et al 12 found no 
difference in quality of life after radiotherapy or surgery (mostly endoscopic laser 
surgery) for early glottic cancer. In this study the patient groups were comparable  
(Tis and T1).  
This is the first study addressing quality of life after a partial laryngectomy versus a 
total laryngectomy for recurrent disease. Initial stage of disease is therefore not a factor-
influencing outcome. However, we should keep in mind that the results might 
underestimate reality. As mentioned before there are some advantages, such being able 
to swim and shower without precautions, after a partial laryngectomy. Also the patient 
might not appreciate the fact that the speech prosthesis must be changed regularly. 
These are only a few examples, which might give a difference in quality of life. These, 
larynx-specific problems could not be investigated, because validated questionnaires 
especially addressing laryngeal problems do not exist.   
In conclusion, we could not confirm our clinical impression that patients with a partial 
laryngectomy are much better off than patients after a total laryngectomy. Those 
studies that do find a difference in QoL cannot make a valid comparison, because of 
selection bias. Because of the good oncological results 7 and the thought of a possible 
under-appreciation of the quality of life after a partial procedure in this study, we 
continue to advocate a partial procedure in suitable patients; however, we do stress even 
more the importance of a very careful patient selection. For future research in this 
particular area, laryngeal-specific questionnaires are mandatory.    
Table I  Results from EORTC QLQ – C30 questionnaire 13,14
Partial
laryngectomy 
median
Total
laryngectomy 
median
Global health status 5.5 6.0
Functional scales 
Physical functioning 
Role functioning 
Emotional functioning 
Cognitive functioning 
Social functioning 
1.4
1.0
1.2
1.0
1.0
1.4
1.5
1.0
1.0
1.0
Symptoms scales 
Fatigue
Nausea and vomiting 
Pain 
Dyspnoea 
Insomnia
Appetite loss 
Constipation
Diarrhea
Financial difficulties 
1.3
1.0
1.0
2.0
1.0
1.0
1.0
1.0
1.0
1.2
1.0
1.0
2.0
1.0
1.0
1.0
1.0
1.0
There are no significant differences between the two groups. 
Table II Results from EORTC QLQ – H & N 35 questionnaire 15
Partial laryngectomy 
median
Total
laryngectomy 
median
Pain 
Swallowing 
Senses problems 
Speech problems 
Trouble with social eating 
Trouble with social contact 
Less sexuality 
Teeth
Opening mouth 
Dry mouth 
Sticky saliva 
Coughing 
Felt ill 
Pain killers 
Nutritional supplements 
Feeding tube 
Weight loss 
Weight gain 
1.0
1.3
1.0* 
1.8
1.0
1.0
2.5
1.0
1.0
1.0
2.0
2.0
1.0
1.0
1.0
1.0
1.0
1.0
1.0
1.3
2.5* 
1.7
1.0
1.0
2.3
1.0
1.0
1.0
1.0
2.0
1.0
1.0
1.0
1.0
1.0
1.0
*: There is a significant difference (p=0.002) in problems with senses between 
    the two groups. 
Table III Results from the Voice Handicap index 16
Partial laryngectomy 
median
Total laryngectomy 
median
Functional 
Emotional 
Physical 
22.0 
21.5 
24.0 
29.0 
24.0 
23.5 
There are no significant differences between the two groups. 
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Abstract
Objective: To analysed different treatment strategies and treatment results  
of hypopharyngeal carcinoma in the Netherlands. 
Design: Retrospective study. 
Setting: Eight head and neck centres in the Netherlands. 
Participants: A total of 893 patients were treated between 1985 and 1994.  
Patients were mostly treated with radiotherapy alone, combined surgery and 
radiotherapy and surgery alone.  
Results: The 5-year survival for the whole group was 26%.  
The 5-year survival for patients treated with curative intention was 32% and treated 
with palliative intention was 5%. The 5-year disease free survival after radiotherapy 
alone was 37%, after surgery alone 41% and after combined therapy 47%. The role of 
chemotherapy could not be investigated due to a small number of patients treated with 
chemotherapy in this period.   
Conclusion: Combined therapy with surgery and radiotherapy has a better survival for 
patients with a hypopharyngeal carcinoma in comparison with radiotherapy alone.  
The N-stage is more important for the prognosis than the T-stage. 
Keywords: hypopharyngeal carcinoma, radiotherapy, surgery, survival
Introduction
Squamous cell carcinoma of the hypopharynx is relatively rare and has the worst 
prognoses of all head and neck cancers, particularly tumours arising in the pyriform 
sinus, the most frequent site of hypopharyngeal origin.1,2 Patients usually present with 
late stage disease often thought to be a result of the larger cross-sectional area permitting 
food to pass until late stage disease.3 In the 1970s most patients were treated with 
surgery, radiotherapy or combination of these two treatment modalities.4 The 5-year 
survival rate for combined surgery with radiotherapy varies between 25% and 60%.3,4
For the purpose of improving survival rates and preserving organ function a third 
treatment modality, chemotherapy in combination with radiotherapy, was introduced.   
There are not many randomised studies available to answer the question which therapy 
has better oncological and functional results.5 Several studies 2,6 described that 
neoadjuvant chemotherapy and radiotherapy is a more effective treatment strategy 
compared to radiotherapy alone. Organ preservation is achieved without compromising 
survival. However, both studies had a small number of patients and do not mention 
functional outcome. For small tumours radiotherapy or surgery alone can be effective.7
A nation wide study was set up to evaluate the results of treatment of patients with 
hypopharyngeal carcinoma in the Netherlands between 1985 and 1994. This 
retrospective study reports methods of treatment and treatment results of patients 
presenting with a hypopharyngeal carcinoma.  
Methods
The eight head and neck centres of the Dutch Cooperative Head and Neck Group 
participated in this nationwide retrospective study analysing all patients treated for a 
hypopharyngeal carcinoma between 1985-1994. Generally over 90% of patients with 
hypopharyngeal cancer in the Netherlands will be treated in or under supervision of one 
of the head and neck centres (Table 1). In each centre records of patients with 
hypopharyngeal carcinoma were reviewed and a standardised questionnaire for each 
patient was completed. The items scored for each patient are presented in Table 2. 
A total of 930 patients were diagnosed with hypopharyngeal carcinoma. Eight patients 
were excluded because they had a non-squamous cell carcinoma. Three patients were left 
out of the study because of incidence before 1985 or incomplete data. Twenty-six 
patients were registered twice. In total 893 patients with squamous cell carcinoma of the 
hypopharynx were included in the study. The population consisited 716 men and 177 
women. The ages of the patients ranged from 33-91 years (average age for males was 61.9 
years and for females 63.3 years) (Fig. 1). 
Data analysis:  
Survival rates were calculated using Kaplan Meier method and compared using the log-
rank test. 
The disease-free survival is calculated as the period from the moment of diagnosis until a 
recurrence occurs. 
Results
Tumour stage 
The tumours were staged according to the UICC 1987 criteria (Table 3). Distribution by 
UICC is as follows: Stage I: 38 patients (4.2 %), Stage II: 88 patients (9.9%), Stage III: 
155 patients (17.3%) and Stage IV: 612 patients (68.5%). 
Treatment 
A total of 704 patients (78.9%) were treated with curative intent. Curative treatment 
consisted mostly of surgery combined with radiotherapy (N = 381) and radiotherapy  
(N = 224). The other treatment modalities were surgery (N = 57), chemotherapy 
combined with radiotherapy (N = 36) and chemotherapy in combination with surgery 
and radiotherapy (N = 6). Palliative treatment was given to 140 patients (15.8%) and 49 
patients (5.4%) received no treatment at all. 
Survival
The overall survival after 5 years for the whole group was 26%. The overall 5-year 
survival for patients treated with curative intent was 32% and for patients treated with 
palliative intent was 5%. In the group of patients who did not receive any treatment, all 
patients died within 6 months. The 5-year disease-free survival for patients treated with 
curative intent was 42%. For patients treated with palliative intent this was 5.6%. The 
5-year disease-free survival for patients in the curative group is significantly different for 
T-stage (p < 0,01) (Fig. 2) and for N-stage (p < 0,01) (Fig. 3). T-stage and N-stage, after 
correction for age, are independent prognostic factors. Difference in N-stage had more 
impact on survival than a difference in T-stage (Table 4). The 5-year disease-free 
survival for patients in the curative group is also significantly different for UICC stages 
(p < 0,01) (Fig. 4). 
In the group of patients treated with curative intent, the 5-year disease-free survival 
significantly differs (p < 0.01) between the treatment modalities. The 5-year disease-free 
survival after combined surgery and radiotherapy was 47%, after surgery alone 41% and 
after radiotherapy 37%. Because of the small number of patients treated with combined 
radiotherapy and chemotherapy, we were not able to calculate a survival rate. 
After treatment with radiotherapy alone, 56% developed recurrent disease (local, 
regional or distant). Forty-nine percent of patients treated with surgery and 
radiotherapy and 54% after treatment with surgery alone developed a recurrence  
(Table 5). 
The 5-year disease-free survival is for stage IV disease is significantly better  (p<0,01) 
after surgery in combination with radiotherapy. In the other disease stages we also found 
a trend that the 5-year disease-free survival is better after combination therapy  
(Table 6).  
Patients and treatment differences between different institutes 
One institute had a different distribution of tumour stage for patients at first 
presentation with 77% of these patients having stage IV disease. The average 
distribution for stage IV disease for all other institutes ranged between 22 and 49%.  
Most institutes treated patients with combined surgery and radiotherapy (Table 7).  
Only in two centres more patients were treated with radiotherapy. 
Discussion
This study presents the results of all patients treated for hypopharyngeal carcinoma in 
the Netherlands over a 10-year period. Carcinoma of the hypopharynx has one of the 
worst prognoses of all head and neck cancers. Symptoms of this disease occur late; 
therefore most patients are diagnosed with advanced stage. In our study 86 % of the 
patients presented with stage III or IV disease. This is comparable with Pingree 1, who 
reported 71 % I stages III and IV. 
The overall 5-year survival of the whole group of patients with hypopharyngeal 
carcinoma was 26%. This is comparable to other studies which reported survival ratios 
varying between 15 and 47%.1,6,8 The disease-free 5-year survival found in this study 
between radiotherapy (37%) and combined surgery and radiotherapy (47%) or surgery 
(41%) is significantly different. This is similar to other studies, 1,6 which also reported a 
worse survival after radiotherapy alone. This is especially reported for late stage disease.6
Similar to Kim 6 we also found that for stage IV hypopharyngeal carcinoma treatment 
with combined therapy is significantly better. For all other stages we found a trend that 
combined therapy is better, but because of the number of patients in these groups no 
statistical significance could not be established. In the Netherlands, most patients are 
treated with combined therapy. Only in two institutes more patients were treated with 
radiotherapy alone in the study period. In our study, a small number of patients were 
treated with chemotherapy and radiotherapy. Therefore, we could not analyse this 
treatment modality. However, in the literature several studies describe the benefit of 
chemotherapy in combination with radiotherapy for head and neck cancer. A large meta-
analysis 5 revealed that the survival rate increased significantly when chemotherapy was 
added to loco regional treatment. However, this study included all head and neck 
cancers. Another study addressing combined chemotherapy and radiotherapy of 
laryngeal cancer showed that organ preservation can be achieved without a difference in 
survival compared to combined surgery and radiotherapy.9
A randomized trial 10 in Europe for treatment of hypopharyngeal carcinoma showed no 
difference in survival after treatment with chemotherapy and radiotherapy compared 
with surgery and radiotherapy. However, with combined chemotherapy and 
radiotherapy the larynx can be preserved in the majority of patients.2,6,10,12 In these 
studies function of the larynx is not evaluated. In a recent study 13 it was found that 
patients with advanced stage laryngeal or hypopharyngeal cancer, laryngeal function 
was impaired after combined treatment with chemotherapy and radiotherapy, which has 
also been our personal experience.    
We therefore suggest that patients with advanced hypopharyngeal cancer without neck 
metastasis should be treated with combined surgery and radiotherapy; for all other 
stages combined surgery and radiotherapy or chemotherapy and radiotherapy appear to 
be equally effective. 
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Table 1:  Head and Neck centres in the Netherlands. 
University hospital of Groningen 
University hospital of Leiden 
University hospital of Utrecht 
University hospital of Nijmegen 
University hospital of Maastricht in combination with the  
Radiotherapeutic Institute of Limburg 
University hospital of Rotterdam  
University hospital of Amsterdam 
Netherlands Cancer Institute 
Table 2:  Items scored for each patient: 
Institute 
Date of birth 
Gender
Date of first histological diagnosis 
Localisation in the hypopharynx 
TNM-classification 
Histological diagnosis 
Intent of primary treatment 
Date of first treatment 
Primary according to institute’s protocol 
Reason for non-protocollar treatment 
Combination of surgical, radiotherapeutic and or chemotherapeutic treatment 
Surgical treatment: 
Date of operation 
Resection with surgery 
 Larynx 
 Pharynx 
 Neck 
 Oesophagus 
Kind of reconstruction 
Radiotherapeutic treatment: 
Date of start radiotherapy  
Doses of radiotherapy 
Total dose at tumour site 
Elective dose on neck 
 Fraction dose 
Chemotherapeutic treatment: 
Date of start chemotherapy 
Intention of chemotherapy 
Number of chemotherapeutic treatments 
Complications from any kind of treatment 
Date of recurrence or residual tumour 
Intention treatment of recurrence 
Combination of surgical, radiotherapeutic and or chemotherapeutic treatment for 
recurrence
Second recurrence 
Date of second recurrence 
Second primary tumour 
Date of second primary tumour 
Localisation of second primary tumour 
Date last follow-up 
Tumour status at date last follow-up 
Date of death  
Tumour status at date of death 
Table 3:  Tumour stage. 
T1 T2 T3 T4 Tx Total
N0 38 88 61 88 2 277
N1 10 52 32 73 0 167
N2 13 62 63 131 0 269
N3 11 12 20 56 1 100
Nx 0 0 0 1 0 1
M0
Subtotal 72 214 176 349 3 817
N0 0 0 0 3 0 3
N1 0 1 2 1 0 4
N2 1 0 1 8 1 11
N3 1 2 1 4 0 8
Nx 1 0 0 0 0 1
M1
Subtotal 3 3 4 16 1 27
N0 2 3 4 4 0 13
N1 0 5 1 4 0 10
N2 2 0 5 12 0 19
N3 0 2 1 3 0 6
Nx 0 0 0 1 3 4
Mx
Subtotal 4 10 11 24 3 52
Total 79 227 191 389 7 893
Table 4:  Odds ratio for T-stage and N-stage. 
T-stage N-Stage 
Odds Ratio (95% CI) 
T2: 1.06 (0.70 – 1.60) 
T3: 1.31 (0.86 – 1.99) 
T4: 1.60 (1.08 – 2.37) 
N1: 1.28 (0.93 – 1.75) 
N2: 1.80 (1.37 – 2.37) 
N3: 3.59 (2.48 – 5.20) 
T-stage: Odds ratio calculated for T2, T3 and T4  tumours compared with T1 
N-stage: Odds ratio calculated for N1, N2 and N3  tumours compared with N0 
Table 5:  Recurrence in the group treated with curative intent. 
No
recurrence
N  (%) 
Local
N  (%) 
Regional 
N  (%) 
Loco
regional 
N  (%) 
Distant
metastases
N  (%) 
Radiotherapy 
N=216
95 (44%) 65 (30%) 34 (16%) 1 (0.5%) 21 (9.7%) 
Radiotherapy 
and surgery 
N=370
189 (51%) 37 (10%) 50 (14%) 1 (0%) 93 (25%) 
Surgery 
N=52
24 (46%) 10 (19%) 11 (21%) 0 7 (14%) 
Table 6:  Five-year disease free survival in different stages of disease  
after different treatment. 
Treatment 5-year disease free survival 
Stage I R: N=27 
RS: N=4 
S: N=6 
54%
75%
60%
Stage II R: N=49 
RS: N=25 
S: N=8 
51%
79%
63%
Stage III R: N=63 
RS: N=62 
S: N=14 
37%
47%
62%
Stage IV R: N=83 
RS: N=287 
S: N=27 
22%
43%   * 
22%
R: Radiotherapy  
RS: Combination therapy radiotherapy and surgery 
S: Surgery 
*: Significantly different (p<0.01)
Table 7:  Treatment modalities in different institutes in the group 
patients treated with curative intent. 
Radiotherapy 
N  (%) 
Radiotherapy and 
surgery
N (%) 
Surgery 
N  (%) 
Institute 1 
N=57
24 (42%) 32 (56%) 1 (2%) 
Institute 2 * 
N=75
27 (36%) 38 (51%) 8 (11%) 
Institute 3 * 
N=77
9 (12%) 60 (78%) 5 (7%) 
Institute 4 * 
N=56
22 (39%) 15 (27%) 7 (13%) 
Institute 5 * 
N=148
33 (22%) 99 (67%) 7 (5%) 
Institute 6 * 
N=107
63 (59%) 29 (27%) 4 (4%) 
Institute 7 * 
N=106
29 (27%) 57 (54%) 16 (15%) 
Institute 8 * 
N=78
17 (22%) 51 (65%) 9 (12%) 
*: Other treatment modalities were performed. Therefore a total of 100 % is 
    not reached. 
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Chapter VI 
The devastation of chemoradiation 
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Abstract
Background: Salvage surgery is a treatment option for patients with residual or 
recurrent disease after chemoradiation. However, salvage surgery in this group of 
patients has a high complication-rate. The aim of this study was to determine the rate of 
complications associated with salvage surgery after chemoradiation in comparison to 
salvage surgery after radiotherapy alone for laryngeal and pharyngeal cancers. 
Methods: Twenty-four patients with salvage surgery after chemoradiation were 
compared to patients who were salvaged after radiotherapy.  
Results: The complication rate in the direct post-operative period was significantly 
higher (92% vs. 50%) in the chemoradiation group. The most frequent complication was 
pharyngocutaneous fistula. The quality of life, measured at least two years after salvage 
surgery, showed a significant difference in social functioning in disadvantage of the 
chemoradiation group.   
Conclusion: With chemoradiation protocols for laryngeal or hypopharyngeal cancers the 
organ can be preserved. However, salvage surgery is accompanied by high complication 
rates.   
Keywords: chemoradiation, salvage surgery, radiotherapy, complications, organ 
preservation 
Introduction
Since the Veterans Affair Cooperative (VA) study 1 was published in the early nineties, 
treatment of advanced laryngeal and hypopharyngeal cancer with chemoradiation has 
become increasingly popular. The VA study 1 reported that approximately two thirds of 
the patients retained their organ after induction chemotherapy and radiotherapy 
without a difference in survival compared to combined surgery and radiotherapy. In a 
prospective study by the Radiation Therapy Oncology Group,2 a similar high rate of 
organ preservation after concomitant chemoradiation was achieved, while survival was 
found to be similar to primary surgical treatment. 
The goal of organ preservation protocols for laryngeal and hypopharyngeal cancer is to 
preserve natural speech and swallowing. In a recent study, Hanna et al 3 showed that 
although chemoradiation and surgery have a different effect on the quality of life, the 
overall QOL scores of both groups seem similar after an average of 15 months. For the 
patients who recur or who have residual disease after organ preservation protocols, 
salvage surgery is the only treatment option. Loss of the larynx is the price for a chance 
of cure. A number of studies report increased complication rates associated with salvage 
surgery compared to primary surgery. 4,5,6
The goal of this study was to determine the rate and severity of complications associated 
with salvage surgery (laryngectomy) after chemoradiation in comparison to salvage 
surgery after radiotherapy alone for laryngeal or hypopharyngeal cancers. Furthermore, 
the Quality of life after salvage surgery after the 2 primary treatment modalities was 
compared. 
Material and methods 
Between 1995 and 2004 twenty-four patients were treated with salvage laryngectomy at 
the department of Otolaryngology Head and Neck Surgery of the Erasmus Medical 
Centre Rotterdam and in the department of Otolaryngology Head and Neck Surgery of 
the University hospital Leiden in the Netherlands after previous chemotherapy and 
radiotherapy. 
The group treated after chemoradiation consisted of sixteen men and seven women. Ages 
ranged between 46 and 71 year. The primary tumour sites were the hypopharynx in 11 
patients, supraglottic larynx in 8 and the base of tongue in 5. (Table I) Previous 
treatment consisted of induction chemotherapy and radiotherapy in 16 patients and 
concomitant chemotherapy and radiotherapy in 8 patients. Seventeen patients were 
salvaged for recurrent disease, 5 patients for residual disease and two patients underwent 
laryngectomy for a second primary tumour.   
In the same period one hundred and three patients were treated with salvage 
laryngectomy for recurrent disease after radiotherapy. This group consisted of ninety-
three men and ten women. Ages ranged between 32 and 85 years.  The primary tumour 
sites were the larynx (glottic (N=65) and supraglottic (N=32)) and the hypopharynx 
(N=6). (Table II)   
The medical records were studied for tumour stage, treatment, operation reports and 
post-operative complications.  
Two different questionnaires were sent to the patients: 1) EORTC Quality of Life 
Questionnaire (QLQ) – C30 Dutch version 3.07,8 2) EORTC – Head & Neck (H & N 35). 9
The EORTC QLQ – C 30 7,8 consists of six functional scales: physical (five items), role 
(two items), emotional (four items), cognitive (two items) and global health status (two 
items); three symptoms scales: fatigue (three items), nausea/vomiting (two items) and 
pain (two items) and six single items: dyspnoea, insomnia, appetite loss, constipation, 
diarrhoea and financial difficulties. In total, there were 30 questions. The patients had to 
answer the questions by indicating one of four categories (1 = not at all, 2 = not much, 3 
= moderate, 4 = very much). Two questions had to be answered on a 7-point scale  
(1 = very bad – 7 = excellent). Higher scores for functional scales represent better quality 
of life. For the symptom oriented scales and items, a higher score corresponds to a worse 
condition.  
The EORTC QLQ – H & N 35 9 is a diagnosis specific questionnaire for patients with 
head and neck cancer. It consisted of 35 questions concerning problems that are 
attributable to the head and neck cancer and side effects of the treatment. The patients 
had to answer the questions by indicating one of four categories (1 = not at all, 2 = not 
much, 3 = moderate, 4 = very much) as in the EORTC QLQ – C30. 7,8 A higher score 
corresponds to a worse Quality of Life.  
Data analysis 
The Mann Whitney U test and the Pearson Chi-square test were used to calculate the 
significant differences between the two groups. 
Results
Of the 24 patients treated with salvage laryngectomy after chemoradiation, nine patients 
were treated with a total laryngectomy with a partial pharyngectomy and a 
reconstruction with a pectoralis major muscle flap. Six patients were treated with a total 
laryngectomy and pharyngectomy while a free jejunum graft was used for 
reconstruction. One patient was treated with a total laryngectomy, pharyngectomy, 
unilateral neck dissection and reconstructed with a jejunum graft and a pectoralis major 
flap. Eight patients had a laryngectomy with primary closure. In seven patients a 
unilateral neck dissection and in 9 patients a bilateral neck dissection was also 
performed. (Table III) 
In the patients who recurred after irradiation, 66 patients underwent a total 
laryngectomy with a partial pharyngectomy and primary closure. In eleven patients a 
total laryngectomy and a neck dissection and a reconstruction with a pectoralis major 
flap were performed. In three cases a reconstruction with a free jejunum graft was 
performed. (Table IV)  
In neither group any per-operative complications were recorded. In the chemoradiation 
group, twenty-two patients (92%) suffered of complications in the direct post-operative 
period (< 3 months). (Table V)  Most of these (N=12, 50%) developed a 
pharyngocutaneous fistula. In only two cases surgical treatment was needed. In all other 
patients conservative treatment of the fistula was successful. Five patients (21%) had 
postoperative haemorrhage and needed surgery. In this group one patient suffered of 
postoperative haemorrhage and also an ischemic jejunum graft, which was replaced by a 
new one.  
In the radiotherapy-alone group, fifty patients (50%) had complications in the post-
operative period (< 3 months). The most frequent complication was again a 
pharyngocutaneous fistula (N=20, 19%). (Table V) Most patients (N=18) were treated 
conservatively. In this group two patients died in the direct post-operative period. Both 
deaths were due to pulmonary failure. 
Late complications (> 3 months postoperatively) in both groups were swallowing 
restrictions (25% in chemoradiation group vs. 8% in radiation group) (Table V) In both 
groups most patients were treated by endoscopy with dilation of the pharynx or upper 
oesophagus. In the chemoradiation group, 2 patients had a near total obstruction of the 
oesophagus necessitating a jejunum graft in one patient and a percutanous gastrostomy 
in another. In the radiation group, pharyngeal dilation was sufficient treatment for all 
patients. The other frequent complication in both groups was constriction of the 
tracheostoma. In the chemoradiation group three patients (13%) needed a surgical 
procedure. In the other group five patients (5%) needed a surgical procedure.  
The Quality of life after was measured in 7 patients after salvage laryngectomy. Eleven 
questionnaires were sent to all patients alive. Seven patients (63%) returned the filled 
questionnaires. In the other group (after radiotherapy) 30 questionnaires were sent out. 
Twenty patients (67%) returned the filled questionnaires. The patients in the 
chemoradiation group had significant more troubles in social functioning and in eating 
with others. They also had more problems with sticky saliva. (Table VI + VII)  Patients 
after salvage surgery after chemoradiation had more social difficulties. These results 
suggest that the quality of life after a longer period is equal in both groups.     
Discussion
Since 1991, after the Veterans Affair (VA) Cooperative study was presented, organ 
preservation protocols consisting of chemoradiation for advanced laryngeal and 
hypopharyngeal cancers became more popular. A large meta-analysis 10 revealed that the 
survival rate increased significantly when chemotherapy was added to loco-regional 
treatment. However, this study included all head and neck cancers. Another study 1
addressing combined chemotherapy and radiotherapy of laryngeal cancer showed that 
organ preservation could be achieved without a difference in survival compared to 
combined surgery and radiotherapy. A randomized trial 11 in Europe for treatment of 
hypopharyngeal carcinoma showed no difference in survival after treatment with 
chemoradiation compared to surgery and radiotherapy. However, with combined 
chemotherapy and radiotherapy the larynx could be preserved in the majority of 
patients.12,13,14,15
Although with chemoradiation the larynx is anatomically preserved, function may be 
impaired. Especially, swallowing can be compromised due to permanent tissue damage 
(radiotherapy induced fibrosis and xerostomia).16
Surgery is reserved for salvage treatment in case of local or regional recurrence. 
However, in this group of patients the postoperative complication rate is high.6 The 
frequency of complications in salvage surgery after induction chemotherapy and 
radiotherapy ranges between 33% 17 and 61%.18 The most frequent complication 
described by Sassler et al 18 were pharyngocutaneous fistula and wound breakdown. 
Kraus et al 17 also found pharyngocutaneous fistula the most frequent complication. In a 
more recent study by Leon et al,5 the post-operative complication rate was 21% 
following salvage surgery after chemoradiation. In this study, pharyngocutaneous fistula 
was the predominant complication. In our study, we found a post-operative complication 
rate of 92%. A reason for the low complication rate found by Leon et al is that relatively 
limited procedures (mostly total laryngectomy alone) were performed.  
We found a significant difference in complication rates associated with surgery after 
chemoradiation vs. radiotherapy alone (92% vs. 50%). In both groups the most frequent 
complication was a pharyngocutaneous fistula, as reported in other studies. Part of the 
reason for this difference can be attributed to the extent of surgery. In the 
chemoradiation group more extensive resections with more extensive reconstructions 
were performed. Also, the primary stages of the cancers were more advanced in this 
group. However, the much higher rate of complications can also partly be attributed to 
the more toxic effect of chemoradiation on tissues compared to radiotherapy alone. 
Histological, the effect of chemoradiation intensifies the changes produced by 
radiotherapy alone, influencing wound healing. There is proportionally greater 
obliterative endarteritis and increased fibrosis.19 We believe that a reconstruction with 
non-irradiated, well-vascularized tissue is necessary for better wound healing. These 
patients might also suffer from pharyngocutaneous fistulas, but we think that the 
healing period is shorter. Teknos 19 described that free tissue transfer might even be 
better for reconstruction of the hypopharynx after chemoradiation. Surgical 
complications are significantly reduced. 
We found no studies comparing complications of salvage surgery after induction versus 
concomitant chemotherapy, an issue that could also not be addressed by us due to small 
patient groups.  
The quality of life was measured at least two years after salvage surgery. The only 
significant difference found was that the patients in the chemoradiation group had more 
trouble in social functioning and in social eating. No studies, including this one have 
addressed short term QoL, which might be influenced by complications suffered.  
In conclusion, although in the majority of patients a functional larynx can be preserved 
with chemoradiation protocols for primary laryngeal or hypopharyngeal cancers, in case 
of recurrent disease salvage surgery is accompanied by high complication rates.  The 
surgeon should keep in mind that chemoradiation not only cures the cancer, but also 
devastates the tissue. Therefore, special care and good planning of the operation is 
necessary. The patients should be well informed about the operation, the direct post-
operative period and the prolonged rehabilitation period. 
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Table I  Primary tumour site and classification in the 
chemoradiation group 
Primary site Classification
Supraglottic larynx 
Hypopharynx 
Base of Tongue 
T4N3M0, T2N2cM0, 
T3N2cM0, T4N1M0, 
T3N0M0, T3N2bM0,  
T3N2aM0, T3N2cM0 
T4N2cM0, T2N2aM0 ,  
T2N2aM0, T4N1M0, 
T3N0M0, T4N2cM0, 
T3N0M0, T3N2cM0, 
T4N2aM0, T4N2cM0,T3N2bM0 
T4N2bM0, T4N0M0, 
T4N2cM0, T4N1M0, 
T4N2bM0
Table II Primary tumour site and classification in the radiation 
group 
Primary site Classification
Larynx      N=97 
Hypopharynx      N=6 
TisN0M0     N=5 
T1N0M0     N=20 
T2N0M0     N=46 
T3N0M0     N=14 
T4N0M0     N=2 
T2N1M0      N=4 
T3N1M0      N=4 
T2N2cM0    N=1 
T3N2cM0    N=1 
T1N0M0     N=3 
T2N0M0     N=1 
T4N0M0     N=1 
T2N1M0      N=1 
Table III Operations performed as salvage surgery after 
 chemoradiation 
Operation N =
Total laryngectomy, partial pharyngectomy, unilateral neck 
dissection
Total laryngectomy, partial pharyngectomy, bilateral neck 
dissection
Total laryngectomy, total pharyngectomy, free jejunum graft 
Total laryngectomy, total pharyngectomy, free jejunum graft, 
unilateral neck dissection 
Total laryngectomy, total pharyngectomy, free jejunum graft, 
bilateral neck dissection 
Total laryngectomy, partial pharyngectomy, Pectoralis major flap 
Total laryngectomy, partial pharyngectomy, unilateral neck 
dissection, Pectoralis major flap 
Total laryngectomy, partial pharyngectomy, bilateral neck 
dissection, Pectoralis major flap 
Total laryngectomy, partial pharyngectomy 
Total laryngectomy, total pharyngectomy, free jejunum graft, 
unilateral neck dissection, Pectoralis major flap 
3
3
2
3
1
1
3
5
2
1
Table IV Operations performed as salvage surgery after radiotherapy 
Operation N =
Total laryngectomy, partial pharyngectomy, unilateral neck 
dissection
Total laryngectomy, partial pharyngectomy, bilateral neck 
dissection
Total laryngectomy, total pharyngectomy, free jejunum graft 
Total laryngectomy, total pharyngectomy, free jejunum graft, 
unilateral neck dissection 
Total laryngectomy, total pharyngectomy, free jejunum graft, 
bilateral neck dissection 
Total laryngectomy, partial pharyngectomy, unilateral neck 
dissection, Pectoralis major flap 
Total laryngectomy, partial pharyngectomy, bilateral neck 
dissection, Pectoralis major flap 
Total laryngectomy, partial pharyngectomy 
Total laryngectomy, partial pharyngectomy, radial forearm free 
flap 
16
6
1
1
1
9
2
66
1
Table V  Post-operative complications 
Complications chemoradiation 
N = 
Radiotherapy
N=
< 3 months Postoperative haemorrhage 
Wound dehiscence 
Fistula
Ischemic jejunum graft 
Pneumothorax 
CVA
Infection of urogenital 
tract
Bleeding of stomach 
Pneumonia 
Death
5 (21%)* 
7 (29%) 
12 (50%)* 
1 (4%) 
1 (4%) 
2 (8%) 
1 (4%) 
1 (4%) 
2 (8%) 
-
3 (3%) 
15 (15%) 
20 (19%) 
-
-
-
-
-
3 (3%) 
2 (2%) 
> 3 months swallowing dysfunction 
Speech problems 
Fistula
Constriction of 
tracheostoma
Pain 
Wound dehiscence 
6 (25%) 
2 (8%) 
2 (8%) 
5 (21%)* 
2 (8%) 
1 (4%) 
8 (8%) 
-
1 (1%) 
9 (9%) 
-
-
*: There is a significant difference (p<0.05) between the two groups. 
Table VI Results from EORTC QLQ – C30 questionnaire 7,8
TLE after 
chemoradiation 
Median 
TLE after 
radiotherapy 
Median 
Global health status 6 5
Functional scales 
Physical functioning 
Role functioning 
Emotional functioning 
Cognitive functioning 
Social functioning 
1.4
1.3
1.3
1.5
2.0* 
1.4
1.8
1.0
1.0
1.0
Symptoms scales 
Fatigue
Nausea and vomiting 
Pain 
Dyspnoea 
Insomnia
Appetite loss 
Constipation
Diarrhoea 
Financial difficulties 
1.7
1.0
1.0
2.0
2.0
1.0
1.0
1.0
2.0
1.3
1.0
1.0
2.0
1.0
1.0
1.0
1.0
1.0
*: There is a significant difference (p<0.05) between the two groups. 
Table VII Results from EORTC QLQ – H & N 35 questionnaire 9
TLE after
chemoradiation 
Median 
TLE after 
radiotherapy 
Median 
Pain 
Swallowing 
Senses problems 
Speech problems 
Trouble with social eating 
Trouble with social contact 
Less sexuality 
Teeth
Opening mouth 
Dry mouth 
Sticky saliva 
Coughing 
Felt ill 
Pain killers 
Nutritional supplements 
Feeding tube 
Weight loss 
Weight gain 
1.3* 
1.5
2.5
1.7
1.5* 
1.2
1.0
1.0
1.0
1.0
2.0* 
1.0
1.0
1.0
1.0
1.0
1.0
1.0
1.0
1.3
2.5
1.3
1.0
1.0
2.3
1.0
1.0
1.0
1.0
1.0
1.0
1.0
1.0
1.0
1.0
1.0
 *: There is a significant difference (p<0.05) between the two groups. 
Chapter VII 
General discussion 
The larynx is the most commonly involved site of head and neck cancer in the 
Netherlands.1 Tumours may arise from any of the three subsites of the larynx: 
supraglottis (30%), glottis (66%) and subglottis (4%). Tumours in different subsites have 
a different prognosis, which is reflected in treatment protocols.   
The Dutch Cooperative Group for Head and Neck Tumours (NWHHT) has established a 
guideline for treatment of laryngeal carcinoma in the different sites and stages.2
Treatment of laryngeal cancer is aimed at tumour control, with increasing emphasis on 
organ preservation, the organ being a functional larynx.  
It has been shown that this approach does not compromise survival and it is nowadays 
the treatment of choice in the majority of patients, even in patients with advanced stage 
disease.2
The Dutch guideline for treatment of laryngeal carcinomas can be summarized  
as follows.  
Carcinoma in situ (Tis) or severe dysplasia of the vocal cords should preferably 
be treated by endoscopic decortification with CO2-laser.3 Radiotherapy is a good 
alternative. CO2-laser treatment is preferable to radiotherapy because it can be used 
repeatedly, while radiotherapy is reserved for bigger recurrences or second primary 
tumours.2
Treatment of choice for T1-laryngeal carcinoma of all sites is radiotherapy. In 
case of superficial growing T1a-carcinoma of the vocal cords, CO2-laser treatment is a 
good alternative. 
For T2-larynx carcinoma with normal mobility of the vocal cords conventional 
radiotherapy is the treatment of choice. For T2-carcinomas with impaired vocal cord 
mobility accelerated radiotherapy is advocated. 
T3 and T4-carcinomas of all sites are treated with accelerated radiotherapy.  
In case of massive cartilage destruction or tumour growth into the soft tissues of the 
neck, or in case of high stage disease with large tumour bulk and functional impairment 
of the larynx, multimodality therapy (usually surgery followed by radiotherapy) is 
indicated. For small supraglottic laryngeal carcinoma a horizontal supraglottic 
laryngectomy or endoscopic partial laryngectomy is a good alternative. However, there 
are criteria, which should be followed strictly for a good result. Patients with a poor 
pulmonary status and swallowing disorders are not the best candidates for a supraglottic 
laryngectomy. In the direct post-operative period, there is a high risk for aspiration and 
this might result in complications in patients with poor pulmonary status. High age (65-
70 years) is considered to be a contraindication. In our opinion biological age should not 
be a contraindication perse. The co-morbidity should be considered a contraindication as 
eluded on in chapters II and III. 
Accelerated radiotherapy achieves better tumour control than conventional 
radiotherapy, but the short-term side effects are more severe. In some institutes, such as 
Rotterdam, all head and neck cancers are treated with accelerated radiotherapy. It must 
be noted that according to the NWHHT guidelines chemoradiation is still considered to 
be experimental.2
The golden standard for treatment of recurrent laryngeal cancer after radiotherapy is a 
total laryngectomy. Total laryngectomy usually allows for wide surgical margins, while 
modern speech prostheses, inserted during the operation, provide good speech 
rehabilitation. However, although opposed by some surgeons, a partial laryngectomy is a 
good alternative to total laryngectomy in selected (chapter II and III) radiotherapy 
failures. Unlike total laryngectomy, which is a well-defined operation, a partial 
laryngectomy is not more than a term nominating a number of technically very different 
procedures all aimed at preserving part of the larynx. The goal of partial laryngectomy is 
adequate tumour control, while preserving a “natural” and functional larynx, avoiding a 
tracheostoma. It is generally assumed that partial laryngectomies result in a better 
quality of life compared to total laryngectomy. Two types of partial laryngectomy for 
recurrent glottic cancer, endoscopic laser surgery and frontolateral partial laryngectomy, 
are discussed (Chapter II). It is shown in our study and the literature 4,5 that in 44% of 
the patients with tumour extension in the anterior commissure and 58 % of the patients 
without extension in the anterior commissure, the larynx can be preserved with CO2-
laser treatment. Outcome is worse when recurrences extent into the anterior commissure 
compared to unilateral extension. A radical removal of the tumour extended in the 
anterior commissure is difficult and therefore considered a contra-indication. These 
tumours are also difficult to visualize completely with an endoscope. Before 1997 an 
external approach was not offered in our institute and some patients refused a total 
laryngectomy for small recurrent tumours. Although they were told that the recurrence 
rate was higher because of anterior commissure involvement, they chose for CO2-laser
treatment. Important is the finding that failure of laser treatment for recurrent glottic 
cancer does not compromise survival, and that these patients can still be salvaged with a 
total laryngectomy.  
Tumours that extent into the anterior commisure are better treated with an external 
approach. An external approach provides wider access and better visualization of the 
tumour, resulting in better surgical margins. In 83% of the patients treated with a 
frontolateral partial laryngectomy tumour control was achieved with preservation of the 
larynx. In the literature control rates vary from 75% to 100%.6-10 Both laser surgery and 
frontolateral partial laryngectomy resulted in good functional results. We concluded that 
if the surgeon is familiar with the different techniques of and indications for partial 
laryngectomy, this could be a good and satisfying treatment in a selected patient group 
with recurrent glottic cancer. The selection criteria for the various procedures are 
described in chapter II.  
Another external partial procedure is the supracricoid laryngectomy with 
cricohyoidoepiglottopexy (CHEP) (chapter III). The concept of this procedure is very 
different from the concept of the procedures described above. While in case of laser 
surgery and fronto-lateral partial laryngectomy as much of the larynx is preserved in 
order to maintain a functional unit, in case of supracricoid laryngectomy with CHEP 
non-diseased tissue is resected in order to create a new functional unit. It had been shown 
that this procedure achieves good oncological and functional outcome in the primary 
treatment of early glottic cancer,11-14 but few reports address supracricoid laryngectomy 
with CHEP for radiation failures. The scarce information available, indicates that 
concern exists about functionality of the remaining larynx after previous radiotherapy.
The healing period and therefore the rehabilitation period might be complicated and 
prolonged due to the effect of radiotherapy on the tissue. In our series of fourteen 
patients with a recurrence after radiotherapy treated with a supracricoid laryngectomy 
with CHEP, no local recurrences and 2 regional recurrences were found. Although, the 
follow up period of this study is relatively short (average 16 months). The disease free 
survival in the literature of the supracricoid laryngectomy with CHEP after 
radiotherapy varies from 83-100%.15-16 But also in these studies the follow-up period is 
also relatively short ( 36 months 16)  and the patient groups are small, the largest group 
being fifteen patients.16 This is understandable because the selection criteria for the 
supracricoid laryngectomy after irradiation failure are strict and should be followed 
without concessions. If concessions are made there is a high risk of poor function and 
increased risk of irradical margins. 
Functional evaluation after the supracricoid laryngectomy with CHEP was measured 
with flexible endoscopic evaluation of swallowing (FEES) and voice evaluation in a 
subgroup of eight patients. We found that swallowing was uncompromised. Pre-and 
post-operative voice evaluation was performed in five patients. The voice measured after 
the operation is worse than pre-operatively. However, eight patients were subjectively 
satisfied with their voice. Two patients with a very soft voice were dissatisfied. An 
explanation for satisfaction with a poor voice could be that most patients are elderly and 
do not use their voice professionally.  
We conclude that supracricoid laryngectomy with cricohyoidoepiglottopexy (CHEP) for 
recurrent glottic laryngeal cancer after radiotherapy appears to be oncologically safe and 
generally gives good functional results. Ongoing experience with the different partial 
procedures has resulted in a shift from fronto-lateral partial laryngectomy towards 
supracricoid laryngectomy with CHEP in our practice. The main reason is better surgical 
margins. Also patients after supracricoid laryngectomy with CHEP are less likely to 
encounter airway problems. The drawback of this procedure however is aspiration, 
particularly during the rehabilitation period, making it less suitable for pulmonary 
compromised patients.  
The treatment of laryngeal cancer has a great impact on a person’s life. In particular 
total laryngectomy affects crucial functions such as breathing, swallowing and speaking. 
Moreover, after a total laryngectomy patients have a permanent tracheostoma. There is 
a cosmetic aspect and some activities, such as swimming, cannot be done as before. They 
will need special care in order to swim. We investigated the quality of life after partial 
laryngectomy versus total laryngectomy for recurrent laryngeal carcinomas. (Chapter 4) 
Twenty-three patients (N=12 partial laryngectomy, N=11 total laryngectomy) with 
recurrent laryngeal cancer after radiotherapy were included in the study. Quality of life 
was measured with two questionnaires: (1) EORTC Quality of Life Questionnaire (QLQ) 
– C30 Dutch version 3.0, (2) EORTC – H & N 35. The only significant differences in 
quality of life were found to be smell and taste related, however by and large both groups 
scored equally well.  
The speech rehabilitation was evaluated with the Voice Handicap Index. Here also no 
differences were found. This result was much in contrast to our expectations. We had 
expected a worse quality of life after a total laryngectomy. One of the reasons why we 
expected to be so was a cosmetic aspect; a second reason was a permanent tracheostoma; 
and a third reason what was known from the literature 17,18 describing a better quality of 
life after a partial laryngectomy versus total laryngectomy. Part of the explanation of 
our findings is that the questionnaires are not larynx specific and a number of specific 
differences, such as influence of a permanent tracheostoma, changing speaking valves 
regularly, may have been missed. Most important is the finding that quality of life of 
patients after total laryngectomy is better than we had expected  
LoTempio et al 18 evaluated quality if life between surgery (total laryngectomy) and 
organ preservation therapy. They also found no significant differences between the two 
groups.  
The implication of these findings is that the selection criteria for partial laryngectomy 
are crucial for the success and that they should be followed strictly. The saying “if in 
doubt, take it out” does reflect our point of view.  
Hypopharyngeal carcinomas have the worst prognosis of all head and neck cancers. 
Tumours metastasise early and patients frequently present with late stage disease. 
Unlike for laryngeal carcinoma, the NWHHT has not established consensus guidelines 
for treatment of hypopharyngeal carcinoma yet. These are expected to be published in 
2006. A retrospective inventory of treatment protocols and outcome in the eight head 
and neck centres in the Netherlands has however been performed in the late nineties 
(Chapter 5). Between 1985 and 1994 eight hundred ninety-three patients were treated for 
hypopharyngeal carcinoma in the Netherlands. It was found that the treatment 
protocols during this period mostly consisted of surgery and radiotherapy, radiotherapy 
alone or surgery alone. Chemoradiation protocols were very rare at that time (36 of 704 
patients). 
The overall 5-year survival for patients treated with curative intention was 32%, while 
the overall survival in the entire group was only 26%. The best results were achieved 
with multimodality therapy: surgery and radiotherapy. The 5-year survival rate in the 
literature 20,21 for combined surgery and radiotherapy varies between 25% and 60%. 
Given the poor prognosis of these tumours, an alternative to total laryngectomy with 
relatively high morbidity is important. Chemoradiation, a multimodality treatment that 
preserves the larynx, has gained popularity over recent years, now being the standard 
treatment for advanced stage head and neck cancer in many centres. Initially, 
chemoradiation protocols mostly consisted of induction chemotherapy followed by 
radiotherapy. The current approach is concomitant chemotherapy and radiotherapy. It 
is felt this gives a superior tumour control,22 but on the other hand toxicity and 
consequently morbidity is increased. The most important reasons to shift from an 
existing treatment protocol to a new treatment protocol are: 1.) better tumour control / 
improved survival and/or 2.) reduction of morbidity. In regard to organ preservation 
several studies 23,24 described that radiotherapy with neoadjuvant chemotherapy is a 
more effective treatment strategy for hypopharyngeal carcinoma than radiotherapy 
alone.
On the other hand, a large randomised trial 25 in Europe showed no difference in survival 
after treatment with induction chemotherapy and radiotherapy compared to surgery and 
radiotherapy in the treatment of hypopharyngeal carcinoma. However, with combined 
chemotherapy and radiotherapy the larynx can be preserved in the majority of 
patients.23,24,26,27 These findings suggest that morbidity can be reduced without 
compromising cure. However, these studies do not address quality of life and the 
function of the larynx was never evaluated. It was recently shown 28 that laryngeal 
functions were impaired after combined treatment with chemotherapy and radiotherapy 
in a group of patients with advanced stage laryngeal or hypopharyngeal cancer. In this 
study voice and swallowing were evaluated after chemoradiation. Vocal analysis showed 
normal results in 1 patient, mild dysphonia in 4, moderate dysphonia in 6, and severe 
dysphonia in 4 patients. Functional swallowing was seen in 3 patients, mild dysphagia in 
7, moderate dysphagia in 2, and severe dysphagia in 2. The success of combined 
treatment with chemotherapy and radiotherapy is mostly based on disease free survival. 
The short-term complications and larynx function after treatment are factors which 
should be investigated, because they may significantly contribute to treatment decisions. 
Another issue to consider is surgery after chemoradiation. It is known that the quality of 
tissues is poor after chemoradiation and surgery in general can be difficult and is 
frequently accompanied by complications.29-33 Chemotherapy seems to have an 
additional effect to radiotherapy to the impairment of wound healing. For example, the 
extent of fibrosis and obliterative endarteritis can increase with combined treatment.33
In case of recurrent or residual hypopharyngeal cancer, surgery is the only treatment 
option left. Complications after surgery and quality of life of twenty-four patients who 
underwent salvage laryngectomy after chemoradiation were studied. (Chapter VI) The 
control group consisted of 103 patients who underwent salvage laryngectomy after 
radiotherapy alone. The complication rate in the direct post-operative period was 
significantly higher (92% vs. 50%) in the chemoradiation group. The most frequent 
complication found was a pharyngocutaneous fistula. Quality of life, measured at least 
two years after salvage surgery, showed that social functioning of the chemoradiation 
group was significantly worse than of the control group. It must be noted that the 
majority of patients in the study were treated with induction chemotherapy followed by 
radiotherapy. Concomitant chemoradiation might even result in a higher short and long-
term morbidity, because of increased toxicity. 
Organ preservation protocols for laryngeal and hypopharyngeal cancer in all different 
forms anatomically preserve the organ while they appear to have a similar oncological 
outcome compared to surgery and radiotherapy. They can however cause a substantial 
amount of morbidity and the function of the organ may not always be preserved.  
Furthermore salvage surgery usually requires more extensive surgery and is frequently 
followed by complications (delayed wound healing, pharyngocutaneous fistula). Long-
term functional outcome and quality of life after chemoradiation protocols for cancer of 
the larynx and hypopharynx are issues that deserve further attention in the near future. 
As in partial laryngectomy after radiotherapy, we must remain critical of indications and 
side effects of chemoradiation protocols while we should realize that quality of life after 
total laryngectomy is not as poor as we might sometimes think. 
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Samenvatting
De primaire behandeling van het larynx- en hypofarynx carcinoom vindt het laatste 
decennium in toenemende mate “orgaansparend”, d.w.z. larynx-sparend, plaats. In geval 
van het larynxcarcinoom betreft de verandering voornamelijk een verschuiving van 
standaard bestralingsprotocollen naar gehyperfractioneerde radiotherapie, terwijl 
hypopharynxcarcinomen tegenwoordig vaak behandeld worden met een combinatie van 
chemotherapie en radiotherapie in plaats van primaire chirurgie. De belangrijkste 
verschuiving in behandelprotocollen hebben zich daardoor afgespeeld op het gebied van 
het hypopharynxcarcinoom. Doel van dit proefschrift is in de eerste plaats te 
onderzoeken of de larynx bij een recidief larynxcarcinoom na bestraling ook 
orgaansparend behandeld kan worden en wat voor gevolgen sparende chirurgie voor de 
larynx functies (slikken en spreken) heeft.  
De tweede doelstelling van dit proefschrift is een beeld te krijgen van behandel-
protocollen voor het hypopharynx carcinoom in Nederland en wat de verschuiving naar 
chemoradiatie protocollen voor gevolgen heeft voor de chirurgische behandeling van de 
recidief carcinomen.  
Hoofdstuk 1 is een algemene inleiding over het larynx- en hypopharynxcarcinoom. De 
incidentie van het larynx- en hypofarynxcarcinoom wordt beschreven en de grootste 
risicofactoren, i.e. roken en alcohol. In het bijzonder wordt op het effect van 
sigarettenrook op het ontstaan van larynx- en hypofarynxcarcinomen nader ingegaan. 
Sigarettenrook bevat diverse stoffen die mutaties in genen kunnen veroorzaken. Deze 
mutaties hebben invloed op enzym-systemen en celregulatie-systemen, waardoor een 
maligne ontaarding van het plaveisel epitheel wordt bevorderd. Verder wordt in dit 
hoofdstuk een overzicht gegeven over de andere hoofdstukken van dit proefschrift. 
In hoofdstuk 2 worden twee partiële laryngectomie technieken beschreven. De indicaties 
voor deze twee technieken worden weergegeven. De oncologische en functionele 
resultaten van de endoscopische CO2-laser behandeling en de fronto-laterale partiële 
laryngectomie voor de behandeling van het recidief glottisch larynxcarcinoom worden 
beschreven. Beide technieken hebben goede oncologische resultaten en er worden weinig 
functionele problemen gevonden. Met de CO2 laser geneest 44% (uitbreiding in de voorste 
commissuur) en 58% (zonder uitbreiding in de voorste commissuur) met behoud van hun 
larynx en met de fronto-laterale partiele laryngectomie in 71%. Belangrijk is dat in geval 
van een nieuw recidief zonder toegenomen risico op uiteindelijk behandelfalen alsnog een 
laryngectomie verricht kan worden. De conclusie luidt dat de beschreven partiële 
laryngectomie technieken, CO2 laser en de fronto-laterale partiele laryngectomie, goede 
behandelings-modaliteiten zijn voor het recidief glottisch larynxcarcinoom, mits men 
zich strikt aan de indicaties houdt. 
In hoofdstuk 3 worden de functionele en oncologische resultaten van een derde partiële 
laryngectomie techniek, de cricohyoidoepiglottopexy (CHEP), beschreven. Met de 
CHEP kan de larynx behouden blijven in 79% van de patiënten. Bij acht patiënten is 
het slikken post-operatief onderzocht door middel van Flexible Endoscopic Evaluation of 
Swallowing (FEES). Aspiratie is bij geen van de patiënten vastgesteld. De stem is pre- en 
post-operatief opgenomen en beoordeeld. De stem is slechter na de operatie, hoewel de 
meeste patiënten subjectief tevreden zijn. Onze conclusie is dat de 
cricohyoidoepiglottopexy (CHEP) oncologisch verantwoord lijkt en functioneel is voor 
de behandeling van het recidief glottisch larynxcarcinoom bij geselecteerde patiënten. 
In hoofdstuk 4 wordt het verschil in kwaliteit van leven onderzocht na behandeling van 
het recidief larynx carcinoom tussen een partiële laryngectomie en een totale 
laryngectomie. Daaronder wordt ook de stem tussen de twee patiënten groepen apart 
beoordeeld. Met behulp van de EORTC Quality of Life Questionnaire (QLQ) – C30 
Dutch version 3.0 en de EORTC – H & N 35 is de kwaliteit van leven onderzocht. Het 
verschil dat gevonden is, betreft de kwaliteit van de reuk en smaak. De stem is 
beoordeeld met de Voice Handicap Index. Er zijn geen verschillen gevonden. Onze 
conclusie luidt dat er weinig verschil in kwaliteit van leven is tussen behandeling met een 
partiële danwel totale laryngectomie.  
In hoofdstuk 5 wordt de behandeling van het hypofarynxcarcinoom in Nederland 
beschreven. De behandeling van het hypofarynxcarcinoom in de periode tussen 1985 en 
1994 in Nederland is bekeken. De grootste groep patiënten is behandeld met 
radiotherapie of met chirurgie gecombineerd met radiotherapie. De overall 5-jaars ziekte-
vrije overleving na curatieve behandeling is 32%.De ziekte-vrije overleving is beter na 
combinatie-therapie. 
In hoofdstuk 6 is gekeken naar complicaties van salvage chirurgie (chirurgie vanwege een 
recidief of residu carcinoom) bij patiënten die eerder behandeld zijn geweest met 
uitsluitend chemoradiatie of met radiotherapie. Het aantal complicaties in de post-
operatieve periode is significant hoger (92% vs. 50%) in de chemoradiatie groep. De 
meest voorkomende complicatie is een faryngo-cutane fistel. Kwaliteit van leven, na een 
langere post-operatieve periode, laat een significant verschil in sociaal functioneren zien 
ten nadele van patiënten na chemoradiatie.  
In de discussie (hoofdstuk 7) wordt een beschouwing van de gevonden resultaten 
gegeven. De belangrijkste conclusie is dat er zeker plaats is voor orgaansparende 
behandelingen, maar dat de post-behandel gevolgen en de morbiditeit moeten worden 
afgewogen tegen de goede kwaliteit van leven die met een totale laryngectomie bereikt 
kan worden.     

Summary
In the last decade the primary treatment of laryngeal and hypopharyngeal cancer was 
shifted towards organ preservation, i.e. preservation of the larynx. The treatment of 
laryngeal cancer was changed from standard radiotherapy towards hyperfractionated 
radiotherapy. Hypopharyngeal cancer is nowadays mostly treated with a combination of 
chemotherapy and radiotherapy instead of primary surgery. Therefore, the greatest shift 
in treatment protocols found was for hypopharyngeal cancer. The goal of this thesis was 
in the first place to find out whether recurrent laryngeal cancer can be treated with 
preservation of the larynx and the consequences of organ preservation for the function of 
the “new” organ. The second goal of this thesis was to find out which treatment 
protocols are used in the Netherlands for hypopharyngeal cancer. Also, to find the 
consequences of chemoradiation protocols for surgical treatment of recurrent 
hypopharyngeal cancer. 
Chapter I is a general introduction of laryngeal and hypopharyngeal cancer. The 
incidences of laryngeal and hypopharyngeal cancer are mentioned. Furthermore, the 
biggest risk factors, being smoking and alcohol, are described. Especially, the effect of 
tobacco smoke on the development of laryngeal and hypopharyngeal cancer is described. 
Tobacco smoke contains several substances, which can cause mutations in genes. The 
mutations deregulate several enzyme systems and cell regulation systems, which cause 
degeneration of squamous cell epithelium. An overview of the other chapters of this 
thesis is given. 
In Chapter II two partial laryngectomy techniques are described. The oncological and 
functional results of the endoscopic CO2 laser and the frontolateral partial laryngectomy 
for the treatment of the recurrent glottic laryngeal cancer are described. The indications 
of both techniques are mentioned. Both techniques have good oncological results and less 
functional problems were found. With the CO2 laser 44-58% of the patients are cured 
with preservation of the larynx; with the frontolateral partial laryngectomy 71% was 
cured. It is important to realize that in case of a new recurrence, a total laryngectomy 
can be performed without an extra risk of failure for therapy. Both partial laryngectomy 
techniques, CO2 laser and frontolateral partial laryngectomy, are good treatment 
modalities for recurrent glottic laryngeal cancer. However, the indications for the 
different techniques are important and should be followed strictly.  
In chapter III the functional and oncological results of the third partial laryngectomy 
technique, cricohyoidoepiglottopexy (CHEP), is described. With the CHEP 79% of the 
patients are cured with preservation of the larynx. In eight patients a Flexible 
Endoscopic Evaluation of Swallowing (FEES) was performed to objectify problems 
swallowing. In none of the patients aspiration was found. Before and after the operation 
the voice was recorded and judged. After the operation the voice is worst. However, most 
patients are satisfied with there voice. The CHEP appears oncologically safe and 
functional for the treatment of recurrent glottic laryngeal cancer in selected patients. 
In chapter IV was investigated whether the quality of life is different after a partial 
laryngectomy versus a total laryngectomy for recurrent laryngeal carcinomas after 
radiotherapy. Also the voice of both groups of patients was judged. The quality of life 
was investigated with the EORTC Quality of Life Questionnaire (QLQ) – C30 Dutch 
version 3.0 and the EORTC – H & N 35 questionnaire. The only difference found was 
smell and taste related. The voice was judged with the Voice Handicap Index. No 
differences between the two groups were found. There are no big differences in quality of 
life after treatment with a partial or a total laryngectomy. This is mainly caused by the 
unexpected good quality of life after a total laryngectomy. 
In chapter V the treatment of hypopharyngeal cancer in the Netherlands is described. 
The treatment of hypopharyngeal cancer in the period 1985 – 1994 was investigated. The 
biggest group of patients was treated with radiotherapy alone or with combined 
radiotherapy and surgery. The overall 5-year disease-free survival after treatment with 
curative intention was 32%. The disease-free survival is better after combined surgery 
and radiotherapy. 
In chapter VI, the complications after salvage surgery in patients prior treated with 
radiotherapy alone or chemoradiation is described. The post-operative complication rate 
is significantly higher (92% vs. 50%) in the chemoradiation group. The most frequent 
complication found was a pharygocutaneous fistula. The quality of life, after a longer 
post-operative period, showed a significant difference in social functioning in 
disadvantage of the chemoradiation group.   
In the general discussion (chapter VII) the found results are discussed. The most 
important conclusion is that there is place for organ preservation therapy, but we must 
remain critical of indications and side effects of organ preservation protocols while we 
should realize that quality of life after total laryngectomy are not as poor as we might 
sometimes think. 
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